☰

Max Essex - Publications

Affiliations: 
Harvard University, Cambridge, MA, United States 
Area:
Microbiology Biology, Immunology, Public Health
Tree Info Similar researchers PubMed Report error

338/500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Kotokwe K, Moyo S, Zahralban-Steele M, Holme MP, Melamu P, Koofhethile CK, Choga WT, Mohammed T, Nkhisang T, Mokaleng B, Maruapula D, Ditlhako T, Bareng O, Mokgethi P, Boleo C, ... ... Essex M, et al. Prediction of Coreceptor Tropism in HIV-1 Subtype C in Botswana. Viruses. 15. PMID 36851617 DOI: 10.3390/v15020403  0.471
2023 Phinius BB, Anderson M, Gobe I, Mokomane M, Choga WT, Mutenga SR, Mpebe G, Pretorius-Holme M, Musonda R, Gaolathe T, Mmalane M, Shapiro R, Makhema J, Lockman S, Novitsky V, ... Essex M, et al. High Prevalence of Hepatitis B Virus Infection Among People With HIV in Rural and Periurban Communities in Botswana. Open Forum Infectious Diseases. 10: ofac707. PMID 36686633 DOI: 10.1093/ofid/ofac707  0.351
2022 Bareng OT, Choga WT, Maphorisa ST, Seselamarumo S, Seatla KK, Mokgethi PT, Maruapula D, Mogwele ML, Ditshwanelo D, Moraka NO, Gobe I, Motswaledi MS, Makhema JM, Musonda R, Shapiro R, ... Essex M, et al. HIV-1C in-House RNA-Based Genotyping Assay for Detection of Drug Resistance Mutations in Samples with Low-Level Viral Loads. Infection and Drug Resistance. 15: 7565-7576. PMID 36582452 DOI: 10.2147/IDR.S388816  0.456
2022 Bhebhe L, Moyo S, Gaseitsiwe S, Pretorius-Holme M, Yankinda EK, Manyake K, Kgathi C, Mmalane M, Lebelonyane R, Gaolathe T, Bachanas P, Ussery F, Letebele M, Makhema J, Wirth KE, ... ... Essex M, et al. Epidemiological and viral characteristics of undiagnosed HIV infections in Botswana. Bmc Infectious Diseases. 22: 710. PMID 36031617 DOI: 10.1186/s12879-022-07698-4  0.503
2022 Bareng OT, Seselamarumo S, Seatla KK, Choga WT, Bakae B, Maruapula D, Kelentse N, Moraka NO, Mokaleng B, Mokgethi PT, Ditlhako TR, Pretorius-Holme M, Mbulawa MB, Lebelonyane R, Bile EC, ... ... Essex M, et al. Doravirine Associated Resistance Mutations in Antiretroviral Therapy Naïve and Experienced Adults with HIV-1 subtype C Infection in Botswana. Journal of Global Antimicrobial Resistance. PMID 35973671 DOI: 10.1016/j.jgar.2022.08.008  0.356
2022 Resch SC, Foote JHA, Wirth KE, Lasry A, Scott JA, Moore J, Shebl FM, Gaolathe T, Feser MK, Lebelonyane R, Hyle EP, Mmalane MO, Bachanas P, Yu L, Makhema JM, ... ... Essex M, et al. Health impact and cost-effectiveness of HIV testing, linkage, and early antiretroviral treatment in the Botswana Combination Prevention Project. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 35420554 DOI: 10.1097/QAI.0000000000002996  0.352
2021 Ragonnet-Cronin M, Golubchik T, Moyo S, Fraser C, Essex M, Novitsky V, Volz E. HIV genetic diversity informs stage of HIV-1 infection among patients receiving antiretroviral therapy in Botswana. The Journal of Infectious Diseases. PMID 34077517 DOI: 10.1093/infdis/jiab293  0.446
2021 Maseng MJ, Tawe L, Thami PK, Seatla KK, Moyo S, Martinelli A, Kasvosve I, Novitsky V, Essex M, Russo G, Gaseitsiwe S, Paganotti GM. Association of Genetic Variation with Efavirenz and Nevirapine Drug Resistance in HIV-1 Patients from Botswana. Pharmacogenomics and Personalized Medicine. 14: 335-347. PMID 33758532 DOI: 10.2147/PGPM.S289471  0.396
2020 Maruapula D, MacLeod IJ, Moyo S, Musonda R, Seatla K, Molebatsi K, Leteane M, Essex M, Gaseitsiwe S, Rowley CF. Use of a mutation-specific genotyping method to assess for HIV-1 drug resistance in antiretroviral-naïve HIV-1 Subtype C-infected patients in Botswana. Aas Open Research. 3: 50. PMID 34036243 DOI: 10.12688/aasopenres.13107.2  0.361
2020 Koofhethile CK, Moyo S, Kotokwe KP, Chang CA, Mokgethi P, Muchoba L, Mokgweetsi S, Makhema J, Lockman S, Gaseitsiwe S, de Oliviera T, Essex M, Shapiro R, Kanki PJ, Novitsky V. Detection of inducible replication-competent HIV-1C provirus despite long-term antiretroviral treatment in perinatally infected adolescents in Botswana. Aids Research and Human Retroviruses. PMID 32935556 DOI: 10.1089/Aid.2020.0097  0.542
2020 Novitsky V, Zahralban-Steele M, Moyo S, Nkhisang T, Maruapula D, McLane MF, Leidner J, Bennett K, Wirth KE, Gaolathe T, Kadima E, Chakalisa U, Holme MP, Lockman S, Mmalane M, ... ... Essex M, et al. Mapping of HIV-1C Transmission Networks Reveals Extensive Spread of Viral Lineages across Villages in Botswana Treatment-as-Prevention Trial. The Journal of Infectious Diseases. PMID 32492145 DOI: 10.1093/Infdis/Jiaa276  0.412
2020 Phinius BB, Anderson M, Bokete R, Mbangiwa T, Choga WT, Baruti K, Makhema J, Musonda R, Blackard JT, Essex M, Moyo S, Marlink R, Gaseitsiwe S. Incidence of hepatitis B virus infection among human immunodeficiency virus-infected treatment naïve adults in Botswana. Medicine. 99: e19341. PMID 32118769 DOI: 10.1097/Md.0000000000019341  0.719
2019 Lockman S, Makhema J, Essex M. Universal Testing and Treatment for HIV Infection in Botswana. Reply. The New England Journal of Medicine. 381: 2180. PMID 31774971 DOI: 10.1056/Nejmc1911065  0.521
2019 Koofhethile CK, Moyo S, Kotokwe KP, Mokgethi P, Muchoba L, Mokgweetsi S, Gaolathe T, Makhema J, Shapiro R, Lockman S, Kanki P, Essex M, Gaseitsiwe S, de Oliveira T, Novitsky V. Undetectable proviral deoxyribonucleic acid in an adolescent perinatally infected with human immunodeficiency virus-1C and on long-term antiretroviral therapy resulted in viral rebound following antiretroviral therapy termination: A case report with implications for clinical care. Medicine. 98: e18014. PMID 31764816 DOI: 10.1097/Md.0000000000018014  0.38
2019 Mupfumi L, Moyo S, Shin SS, Wang Q, Zetola N, Molebatsi K, Nnawa J, Kgwaadira BT, Bewlay L, Chebani T, Iketleng T, Mogashoa T, Makhema J, Musonda RM, Essex M, et al. High incidence of tuberculosis in the first year of antiretroviral therapy in the Botswana National antiretroviral therapy programme between 2011 and 2015. Aids (London, England). 33: 2415-2422. PMID 31764106 DOI: 10.1097/Qad.0000000000002363  0.438
2019 Bhebhe L, Anderson M, Souda S, Choga WT, Zumbika E, Shaver ZM, Mbangiwa T, Phinius BB, Banda CC, Melamu P, Musonda RM, Essex M, Blackard JT, Moyo S, Gaseitsiwe S. Molecular characterization of hepatitis C virus in liver disease patients in Botswana: a retrospective cross-sectional study. Bmc Infectious Diseases. 19: 875. PMID 31640596 DOI: 10.1186/S12879-019-4514-1  0.565
2019 Mupfumi L, Moyo S, Shin SS, Wang Q, Zetola N, Molebatsi K, Nnawa J, Kgwaadira BT, Bewlay L, Chebani T, Iketleng T, Mogashoa T, Makhema J, Musonda RM, Essex M, et al. High Incidence of tuberculosis in the first year of antiretroviral therapy in the Botswana National ART programme between 2011 and 2015. Aids (London, England). PMID 31490231 DOI: 10.1097/QAD.0000000000002363  0.337
2019 Essex M, Makhema J, Lockman S. Reaching 90-90-90 in Botswana. Current Opinion in Hiv and Aids. PMID 31449090 DOI: 10.1097/COH.0000000000000580  0.339
2019 Zash R, Holmes L, Diseko M, Jacobson DL, Brummel S, Mayondi G, Isaacson A, Davey S, Mabuta J, Mmalane M, Gaolathe T, Essex M, Lockman S, Makhema J, Shapiro RL. Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana. The New England Journal of Medicine. PMID 31329379 DOI: 10.1056/NEJMoa1905230  0.33
2019 Makhema J, Wirth KE, Pretorius Holme M, Gaolathe T, Mmalane M, Kadima E, Chakalisa U, Bennett K, Leidner J, Manyake K, Mbikiwa AM, Simon SV, Letlhogile R, Mukokomani K, van Widenfelt E, ... ... Essex M, et al. Universal Testing, Expanded Treatment, and Incidence of HIV Infection in Botswana. The New England Journal of Medicine. 381: 230-242. PMID 31314967 DOI: 10.1056/Nejmoa1812281  0.465
2019 Chakalisa U, Wirth K, Bennett K, Kadima E, Manyake K, Gaolathe T, Bachanas P, Marukutira T, Lebelonyane R, Dryden-Peterson S, Butler L, Mmalane M, Makhema J, Roland ME, Pretorius-Holme M, ... Essex M, et al. Self-reported risky sexual practices among adolescents and young adults in Botswana. Southern African Journal of Hiv Medicine. 20: 899. PMID 31308965 DOI: 10.4102/Sajhivmed.V20I1.899  0.433
2019 Moyo S, Gaseitsiwe S, Zahralban-Steele M, Maruapula D, Nkhisang T, Mokaleng B, Mohammed T, Ditlhako TR, Bareng OT, Mokgethi TP, van Widenfelt E, Pretorius-Holme M, Mine MO, Raizes E, Yankinda EK, ... ... Essex M, et al. Low rates of nucleoside reverse transcriptase inhibitor and nonnucleoside reverse transcriptase inhibitor drug resistance in Botswana. Aids (London, England). 33: 1073-1082. PMID 30946161 DOI: 10.1097/Qad.0000000000002166  0.354
2018 Choga WT, Anderson M, Zumbika E, Moyo S, Mbangiwa T, Phinius BB, Melamu P, Kayembe MK, Kasvosve I, Sebunya TK, Blackard JT, Essex M, Musonda RM, Gaseitsiwe S. Molecular characterization of hepatitis B virus in blood donors in Botswana. Virus Genes. PMID 30382563 DOI: 10.1007/S11262-018-1610-Z  0.624
2018 Moyo S, Gaseitsiwe S, Mohammed T, Pretorius Holme M, Wang R, Kotokwe KP, Boleo C, Mupfumi L, Yankinda EK, Chakalisa U, van Widenfelt E, Gaolathe T, Mmalane MO, Dryden-Peterson S, Mine M, ... ... Essex M, et al. Cross-sectional estimates revealed high HIV incidence in Botswana rural communities in the era of successful ART scale-up in 2013-2015. Plos One. 13: e0204840. PMID 30356287 DOI: 10.1371/Journal.Pone.0204840  0.548
2018 Anderson M, Choga WT, Moyo S, Bell TG, Mbangiwa T, Phinius BB, Bhebhe L, Sebunya TK, Lockman S, Marlink R, Kramvis A, Essex M, Musonda RM, Blackard JT, Gaseitsiwe S. Molecular Characterization of Near Full-Length Genomes of Hepatitis B Virus Isolated from Predominantly HIV Infected Individuals in Botswana. Genes. 9. PMID 30205537 DOI: 10.3390/Genes9090453  0.678
2018 Anderson M, Choga WT, Moyo S, Bell TG, Mbangiwa T, Phinius BB, Bhebhe L, Sebunya TK, Makhema J, Marlink R, Kramvis A, Essex M, Musonda RM, Blackard JT, Gaseitsiwe S. In Silico Analysis of Hepatitis B Virus Occult Associated Mutations in Botswana Using a Novel Algorithm. Genes. 9. PMID 30134551 DOI: 10.3390/Genes9090420  0.575
2018 Mupfumi L, Moyo S, Molebatsi K, Thami PK, Anderson M, Mogashoa T, Iketleng T, Makhema J, Marlink R, Kasvosve I, Essex M, Musonda RM, Gaseitsiwe S. Correction: Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana. Plos One. 13: e0198711. PMID 29856867 DOI: 10.1371/journal.pone.0198711  0.324
2018 Mbangiwa T, Kasvosve I, Anderson M, Thami PK, Choga WT, Needleman A, Phinius BB, Moyo S, Leteane M, Leidner J, Blackard JT, Mayondi G, Kammerer B, Musonda RM, Essex M, et al. Chronic and Occult Hepatitis B Virus Infection in Pregnant Women in Botswana. Genes. 9. PMID 29772814 DOI: 10.3390/Genes9050259  0.677
2018 Novitsky V, Gaolathe T, Mmalane M, Moyo S, Chakalisa U, Kadima Yankinda E, Marukutira T, Pretorius Holme M, Sekoto T, Gaseitsiwe S, Musonda R, van Widenfelt E, Powis KM, Khan N, Dryden-Peterson S, ... ... Essex M, et al. Lack of Virological Suppression among Young HIV-Positive Adults in Botswana. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 29771781 DOI: 10.1097/Qai.0000000000001715  0.548
2018 Moyo S, Gaseitsiwe S, Powis KM, Pretorius Holme M, Mohammed T, Zahralban-Steele M, Yankinde EK, Maphorisa C, Abrams W, Lebelonyane R, Manyake K, Sekoto T, Mmalane M, Gaolathe T, Wirth KE, ... ... Essex M, et al. Undisclosed antiretroviral drug use in Botswana: implication for national estimates. Aids (London, England). PMID 29762166 DOI: 10.1097/Qad.0000000000001862  0.453
2018 Diphoko T, Gaseitsiwe S, Kasvosve I, Moyo S, Okatch H, Musonda R, Wainberg MA, Makhema J, Marlink R, Novitsky V, Essex M. Prevalence of Rilpivirine and Etravirine resistance mutations in HIV-1 Subtype C- infected patients failing Nevirapine or Efavirenz-based combination antiretroviral therapy in Botswana. Aids Research and Human Retroviruses. PMID 29732907 DOI: 10.1089/Aid.2017.0135  0.529
2018 Powis KM, Lockman S, Ajibola G, Hughes MD, Bennett K, Leidner J, Batlang O, Botebele K, Moyo S, van Widenfelt E, Makhema J, Petlo C, Jibril HB, McIntosh K, Essex M, et al. Similar HIV protection from four weeks of zidovudine versus nevirapine prophylaxis among formula-fed infants in Botswana. Southern African Journal of Hiv Medicine. 19: 751. PMID 29707385 DOI: 10.4102/Sajhivmed.V19I1.751  0.46
2018 Mupfumi L, Moyo S, Molebatsi K, Thami PK, Anderson M, Mogashoa T, Iketleng T, Makhema J, Marlink R, Kasvosve I, Essex M, Musonda RM, Gaseitsiwe S. Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana. Plos One. 13: e0192030. PMID 29385208 DOI: 10.1371/Journal.Pone.0192030  0.458
2018 Moyo S, Wilkinson E, Vandormael A, Wang R, Weng J, Kotokwe KP, Gaseitsiwe S, Musonda R, Makhema J, Essex M, Engelbrecht S, de Oliveira T, Novitsky V. A1 Pairwise diversity and tMRCA as potential markers of HIV infection recency Virus Evolution. 4. DOI: 10.1093/Ve/Vey010  0.495
2017 Arikawa S, Rollins N, Jourdain G, Humphrey J, Kourtis AP, Hoffman I, Essex M, Farley T, Coovadia HM, Gray G, Kuhn L, Shapiro R, Leroy V, Bollinger RC, Onyango-Makumbi C, et al. Contribution of maternal ART and breastfeeding to 24-month survival in HIV-exposed uninfected children: an individual pooled analysis of African and Asian studies. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29272387 DOI: 10.1093/Cid/Cix1102  0.511
2017 N'Guessan KF, Anderson M, Phinius B, Moyo S, Malick A, Mbangiwa T, Choga WT, Makhema J, Marlink R, Essex M, Musonda R, Gaseitsiwe S, Blackard JT. The Impact of Human Pegivirus on CD4 Cell Count in HIV-Positive Persons in Botswana. Open Forum Infectious Diseases. 4: ofx222. PMID 29255726 DOI: 10.1093/Ofid/Ofx222  0.724
2017 Essex M. The end of AIDS? The Lancet. Public Health. 2: e205-e206. PMID 29253481 DOI: 10.1016/S2468-2667(17)30070-1  0.34
2017 Novitsky V, Prague M, Moyo S, Gaolathe T, Mmalane M, Kadima Yankinda E, Chakalisa U, Lebelonyane R, Khan N, Powis KM, Widenfelt E, Gaseitsiwe S, Dryden-Peterson SL, Pretorius Holme M, De Gruttola V, ... ... Essex M, et al. High HIV-1 RNA among Newly Diagnosed People in Botswana. Aids Research and Human Retroviruses. PMID 29214845 DOI: 10.1089/Aid.2017.0214  0.556
2017 Campa A, Baum MK, Bussmann H, Martinez SS, Farahani M, van Widenfelt E, Moyo S, Makhema J, Essex M, Marlink R. The effect of micronutrient supplementation on active TB incidence early in HIV infection in Botswana. Nutrition and Dietary Supplements. 2017: 37-45. PMID 29187783 DOI: 10.2147/NDS.S123545  0.328
2017 Powis KM, Souda S, Lockman S, Ajibola G, Bennett K, Leidner J, Hughes MD, Moyo S, van Widenfelt E, Jibril HB, Makhema J, Essex M, Shapiro RL. Cotrimoxazole prophylaxis was associated with enteric commensal bacterial resistance among HIV-exposed infants in a randomized controlled trial, Botswana. Journal of the International Aids Society. 20. PMID 29119726 DOI: 10.1002/Jia2.25021  0.461
2017 Ryan K, Anderson M, Gyurova I, Ambroggio L, Moyo S, Sebunya T, Makhema J, Marlink R, Essex M, Musonda R, Gaseitsiwe S, Blackard JT. High Rates of Occult Hepatitis B Virus Infection in HIV-Positive Individuals Initiating Antiretroviral Therapy in Botswana. Open Forum Infectious Diseases. 4: ofx195. PMID 29062862 DOI: 10.1093/Ofid/Ofx195  0.704
2017 Zash R, Jacobson DL, Diseko M, Mayondi G, Mmalane M, Essex M, Petlo C, Lockman S, Makhema J, Shapiro RL. Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy. Jama Pediatrics. e172222. PMID 28783807 DOI: 10.1001/Jamapediatrics.2017.2222  0.464
2017 Ratmann O, Wymant C, Colijn C, Danaviah S, Essex M, Frost SDW, Gall A, Gaiseitsiwe S, Grabowski M, Gray R, Guindon S, von Haeseler A, Kaleebu P, Kendall M, Kozlov A, et al. HIV-1 full-genome phylogenetics of generalized epidemics in sub-Saharan Africa: impact of missing nucleotide characters in next-generation sequences. Aids Research and Human Retroviruses. PMID 28540766 DOI: 10.1089/Aid.2017.0061  0.429
2017 Lockman S, Hughes M, Powis K, Ajibola G, Bennett K, Moyo S, van Widenfelt E, Leidner J, McIntosh K, Mazhani L, Makhema J, Essex M, Shapiro R. Effect of co-trimoxazole on mortality in HIV-exposed but uninfected children in Botswana (the Mpepu Study): a double-blind, randomised, placebo-controlled trial. The Lancet. Global Health. 5: e491-e500. PMID 28395844 DOI: 10.1016/S2214-109X(17)30143-2  0.515
2017 Moyo S, Wilkinson E, Vandormael A, Wang R, Weng J, Kotokwe KP, Gaseitsiwe S, Musonda R, Makhema J, Essex M, Engelbrecht S, de Oliveira T, Novitsky V. Pairwise diversity and tMRCA as potential markers for HIV infection recency. Medicine. 96: e6041. PMID 28178146 DOI: 10.1097/Md.0000000000006041  0.582
2017 Xie W, Agniel D, Shevchenko A, Malov SV, Svitin A, Cherkasov N, Baum MK, Campa A, Gaseitsiwe S, Bussmann H, Makhema J, Marlink RG, Novitsky V, Lee TH, Cai T, ... ... Essex M, et al. Genome-Wide Analyses Reveal Gene Influence on HIV Disease Progression and HIV-1C Acquisition in Southern Africa. Aids Research and Human Retroviruses. PMID 28132517 DOI: 10.1089/Aid.2016.0017  0.553
2017 Zash RM, Souda S, Leidner J, Binda K, Hick C, Powis K, Makhema J, Mmalane M, Essex M, Lockman S, Shapiro RL. High Proportion of Deaths Attributable to HIV Among Postpartum Women in Botswana Despite Widespread Uptake of Antiretroviral Therapy. Aids Patient Care and Stds. 31: 14-19. PMID 28051898 DOI: 10.1089/Apc.2016.0154  0.513
2016 Novitsky V, Moyo S, Wang R, Gaseitsiwe S, Essex M. Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages. Plos One. 11: e0166746. PMID 27893822 DOI: 10.1371/Journal.Pone.0166746  0.592
2016 Anderson M, Gaseitsiwe S, Moyo S, Thami KP, Mohammed T, Setlhare D, Sebunya TK, Powell EA, Makhema J, Blackard JT, Marlink R, Essex M, Musonda RM. Slow CD4(+) T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana. Open Forum Infectious Diseases. 3: ofw140. PMID 27800524 DOI: 10.1093/Ofid/Ofw140  0.724
2016 Moyo S, Mohammed T, Wirth KE, Prague M, Bennett K, Holme MP, Mupfumi L, Sebogodi P, Moraka NO, Boleo C, Maphorisa CN, Seraise B, Gaseitsiwe S, Musonda RM, van Widenfelt E, ... ... Essex M, et al. Point-of-care Cepheid Xpert HIV-1 Viral Load Test in Rural African Communities is Feasible and Reliable. Journal of Clinical Microbiology. PMID 27733636 DOI: 10.1128/Jcm.01594-16  0.494
2016 Zash RM, Shapiro RL, Leidner J, Wester C, McAdam AJ, Hodinka RL, Thior I, Moffat C, Makhema J, McIntosh K, Essex M, Lockman S. The aetiology of diarrhoea, pneumonia and respiratory colonization of HIV-exposed infants randomized to breast- or formula-feeding. Paediatrics and International Child Health. 36: 189-97. PMID 27595698 DOI: 10.1179/2046905515Y.0000000038  0.412
2016 Moyo S, Vandormael A, Wilkinson E, Engelbrecht S, Gaseitsiwe S, Kotokwe KP, Musonda R, Tanser F, Essex M, Novitsky V, de Oliveira T. Analysis of Viral Diversity in Relation to the Recency of HIV-1C Infection in Botswana. Plos One. 11: e0160649. PMID 27552218 DOI: 10.1371/Journal.Pone.0160649  0.539
2016 Moyo S, Kotokwe KP, Mohammed T, Boleo C, Mupfumi L, Chishala S, Tsalaile L, Bussmann H, Gaseitsiwe S, Musonda R, Makhema J, Baum MK, Marlink RG, Engelbrecht S, Essex M, et al. Low False Recent Rate of Limiting Antigen-Avidity Assay Combined with HIV-1 RNA Data in Botswana. Aids Research and Human Retroviruses. PMID 27481530 DOI: 10.1089/Aid.2016.0127  0.54
2016 Zash R, Souda S, Leidner J, Ribaudo H, Binda K, Moyo S, Powis KM, Petlo C, Mmalane M, Makhema J, Essex M, Lockman S, Shapiro R. HIV-exposed children account for more than half of 24-month mortality in Botswana. Bmc Pediatrics. 16: 103. PMID 27439303 DOI: 10.1186/S12887-016-0635-5  0.49
2016 Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, ... ... Essex M, et al. Antiretroviral Therapy for the Prevention of HIV-1 Transmission. The New England Journal of Medicine. PMID 27424812 DOI: 10.1056/Nejmoa1600693  0.453
2016 Mukudu H, Martinson N, Sartorius B, Coetzee J, Dietrich J, Mokgatswana K, Jewkes R, Gray GE, Dugas M, Béhanzin L, Guédou FA, Gagnon M, Alary M, Rutakumwa R, Mbonye M, ... ... Essex M, et al. Afri-Can Forum 2 Bmc Infectious Diseases. 16: 315. PMID 27410689 DOI: 10.1186/S12879-016-1466-6  0.423
2016 Rossenkhan R, MacLeod IJ, Brumme ZL, Magaret C, Sebunya TK, Musonda R, Gashe BA, Novitsky V, Edlefsen P, Essex M. Transmitted / founder HIV-1 subtype C viruses show distinctive signature patterns in Vif, Vpr and Vpu that are under subsequent immune pressure during early infection. Aids Research and Human Retroviruses. PMID 27349335 DOI: 10.1089/Aid.2015.0330  0.478
2016 Ogwu A, Moyo S, Powis K, Asmelash A, Lockman S, Moffat C, Leidner J, Makhema J, Essex M, Shapiro R. Predictors of Early Breastfeeding Cessation among HIV-infected women in Botswana. Tropical Medicine & International Health : Tm & Ih. PMID 27224454 DOI: 10.1111/Tmi.12729  0.542
2016 Gaolathe T, Wirth KE, Holme MP, Makhema J, Moyo S, Chakalisa U, Yankinda EK, Lei Q, Mmalane M, Novitsky V, Okui L, van Widenfelt E, Powis KM, Khan N, Bennett K, ... ... Essex M, et al. Botswana's progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey. The Lancet. Hiv. 3: e221-30. PMID 27126489 DOI: 10.1016/S2352-3018(16)00037-0  0.414
2016 Martinez SS, Campa A, Bussmann H, Moyo S, Makhema J, Huffman FG, Williams OD, Essex M, Marlink R, Baum MK. Effect of BMI and fat mass on HIV disease progression in HIV-infected, antiretroviral treatment-naïve adults in Botswana. The British Journal of Nutrition. 115: 2114-21. PMID 27087233 DOI: 10.1017/S0007114516001409  0.392
2016 Novitsky V, Zahralban-Steele M, McLane MF, Moyo S, van Widenfelt E, Gaseitsiwe S, Makhema J, Essex M. Correction for Novitsky et al., Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering. Journal of Clinical Microbiology. 54: 1175. PMID 27016593 DOI: 10.1128/Jcm.00190-16  0.505
2016 Rowley CF, MacLeod IJ, Maruapula D, Lekoko B, Gaseitsiwe S, Mine M, Essex M. Sharp increase in rates of HIV transmitted drug resistance at antenatal clinics in Botswana demonstrates the need for routine surveillance. The Journal of Antimicrobial Chemotherapy. 71: 1361-6. PMID 26929269 DOI: 10.1093/jac/dkv500  0.364
2016 Farahani M, Novitsky V, Wang R, Bussmann H, Sikhulile M, Musonda R, Moeti T, Makhema J, Essex M, Marlink RG. Prognostic value of HIV-1 RNA on CD4 trajectories and disease progression among antiretroviral-naïve HIV-infected adults in Botswana: a joint modeling analysis. Aids Research and Human Retroviruses. PMID 26830351 DOI: 10.1089/Aid.2015.0348  0.518
2016 Powis KM, Smeaton L, Hughes MD, Tumbare EA, Souda S, Jao J, Wirth KE, Makhema J, Lockman S, Fawzi W, Essex M, Shapiro RL. In-utero triple antiretroviral exposure associated with decreased growth among HIV-exposed uninfected infants in Botswana. Aids (London, England). 30: 211-20. PMID 26684818 DOI: 10.1097/Qad.0000000000000895  0.515
2015 Novitsky V, Kühnert D, Moyo S, Widenfelt E, Okui L, Essex M. Phylodynamic analysis of HIV sub-epidemics in Mochudi, Botswana. Epidemics. 13: 44-55. PMID 26616041 DOI: 10.1016/j.epidem.2015.07.002  0.444
2015 Moyo S, Wilkinson E, Novitsky V, Vandormael A, Gaseitsiwe S, Essex M, Engelbrecht S, de Oliveira T. Identifying Recent HIV Infections: From Serological Assays to Genomics. Viruses. 7: 5508-24. PMID 26512688 DOI: 10.3390/V7102887  0.556
2015 Iketleng T, Moyo S, Gaseitsiwe S, Nyombi B, Mitchell RM, Makhema J, Baum MK, Marlink R, Essex M, Musonda R. Plasma Cytokine Levels in Chronic Asymptomatic HIV-1 Subtype C Infection as an Indicator of Disease Progression in Botswana: A Retrospective Case Control Study. Aids Research and Human Retroviruses. PMID 26414751 DOI: 10.1089/AID.2015.0163  0.307
2015 Zash R, Souda S, Chen JY, Binda K, Dryden-Peterson S, Lockman S, Mmalane M, Makhema J, Essex M, Shapiro R. Reassuring Birth Outcomes with Tenofovir/Emtricitabine/Efavirenz used for Prevention of Mother to Child Transmission of HIV in Botswana. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 26379069 DOI: 10.1097/Qai.0000000000000847  0.429
2015 Anderson M, Gaseitsiwe S, Moyo S, Wessels MJ, Mohammed T, Sebunya TK, Powell EA, Makhema J, Blackard JT, Marlink R, Essex M, Musonda RM. Molecular characterisation of hepatitis B virus in HIV-1 subtype C infected patients in Botswana. Bmc Infectious Diseases. 15: 335. PMID 26268355 DOI: 10.1186/S12879-015-1096-4  0.67
2015 Zash RM, Shapiro RL, Leidner J, Wester C, McAdam AJ, Hodinka RL, Thior I, Moffat C, Makhema J, McIntosh K, Essex M, Lockman S. The aetiology of diarrhoea, pneumonia and respiratory colonization of HIV-exposed infants randomized to breast- or formula-feeding. Paediatrics and International Child Health. 2046905515Y000000003. PMID 26052819 DOI: 10.1179/2046905515Y.0000000038  0.32
2015 Novitsky V, Zahralban-Steele M, McLane MF, Moyo S, van Widenfelt E, Gaseitsiwe S, Makhema J, Essex M. Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering. Journal of Clinical Microbiology. 53: 2581-92. PMID 26041893 DOI: 10.1128/JCM.00756-15  0.486
2015 Novitsky V, Bussmann H, Okui L, Logan A, Moyo S, van Widenfelt E, Mmalane M, Lei Q, Holme MP, Makhema J, Lockman S, Degruttola V, Essex M. Estimated age and gender profile of individuals missed by a home-based HIV testing and counselling campaign in a Botswana community. Journal of the International Aids Society. 18: 19918. PMID 26028155 DOI: 10.7448/Ias.18.1.19918  0.511
2015 Mackelprang RD, Scoville CW, Cohen CR, Ondondo RO, Bigham AW, Celum C, Campbell MS, Essex M, Wald A, Kiarie J, Ronald A, Gray G, Lingappa JR. Toll-like receptor gene variants and bacterial vaginosis among HIV-1 infected and uninfected African women. Genes and Immunity. PMID 25928881 DOI: 10.1038/Gene.2015.13  0.343
2015 Novitsky V, Moyo S, Lei Q, DeGruttola V, Essex M. Importance of Viral Sequence Length and Number of Variable and Informative Sites in Analysis of HIV Clustering. Aids Research and Human Retroviruses. 31: 531-42. PMID 25560745 DOI: 10.1089/Aid.2014.0211  0.505
2015 Moyo S, Wilkinson E, Novitsky V, Vandormael A, Gaseitsiwe S, Essex M, Engelbrecht S, De Oliveira T. Identifying recent HIV infections: From serological assays to genomics Viruses. 7: 5508-5524. DOI: 10.3390/v7102887  0.434
2015 Anderson M, Gaseitsiwe S, Moyo S, Wessels MJC, Mohammed T, Sebunya TK, Powell EA, Makhema J, Blackard JT, Marlink R, Essex M, Musonda RM. Molecular characterisation of hepatitis B virus in HIV-1 subtype C infected patients in Botswana Bmc Infectious Diseases. 15. DOI: 10.1186/s12879-015-1096-4  0.693
2014 Powis K, Lockman S, Smeaton L, Hughes MD, Fawzi W, Ogwu A, Moyo S, van Widenfelt E, von Oettingen J, Makhema J, Essex M, Shapiro RL. Vitamin D insufficiency in HIV-infected pregnant women receiving antiretroviral therapy is not associated with morbidity, mortality or growth impairment in their uninfected infants in Botswana. The Pediatric Infectious Disease Journal. 33: 1141-7. PMID 25037041 DOI: 10.1097/Inf.0000000000000428  0.413
2014 Kiwelu IE, Novitsky V, Kituma E, Margolin L, Baca J, Manongi R, Sam N, Shao J, McLane MF, Kapiga SH, Essex M. HIV-1 pol diversity among female bar and hotel workers in Northern Tanzania. Plos One. 9: e102258. PMID 25003939 DOI: 10.1371/journal.pone.0102258  0.374
2014 Shao ER, Kifaro EG, Chilumba IB, Nyombi BM, Moyo S, Gaseitsiwe S, Musonda R, Johannessen A, Kibiki G, Essex M. HIV-1 drug mutations in children from northern Tanzania. The Journal of Antimicrobial Chemotherapy. 69: 1928-32. PMID 24729604 DOI: 10.1093/Jac/Dku087  0.491
2014 Russell ES, Mohammed T, Smeaton L, Jorowe B, MacLeod IJ, Hoffman RM, Currier JS, Moyo S, Essex M, Lockman S. Immune activation markers in peripartum women in Botswana: association with feeding strategy and maternal morbidity. Plos One. 9: e89928. PMID 24657960 DOI: 10.1371/Journal.Pone.0089928  0.451
2014 Grinsztejn B, Hosseinipour MC, Ribaudo HJ, Swindells S, Eron J, Chen YQ, Wang L, Ou SS, Anderson M, McCauley M, Gamble T, Kumarasamy N, Hakim JG, Kumwenda J, Pilotto JH, ... ... Essex M, et al. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. The Lancet. Infectious Diseases. 14: 281-90. PMID 24602844 DOI: 10.1016/S1473-3099(13)70692-3  0.534
2014 Kahle EM, Kashuba A, Baeten JM, Fife KH, Celum C, Mujugira A, Essex M, De Bruyn G, Wald A, Donnell D, John-Stewart G, Delany-Moretlwe S, Mugo NR, Farquhar C, Lingappa JR, et al. Unreported antiretroviral use by HIV-1-infected participants enrolling in a prospective research study Journal of Acquired Immune Deficiency Syndromes. 65: e90-e94. PMID 24442233 DOI: 10.1097/Qai.0B013E3182A2Db02  0.562
2014 Zash RM, Ajose-Popoola O, Stordal K, Souda S, Ogwu A, Dryden-Peterson S, Powis K, Lockman S, Makhema J, Essex M, Shapiro RL. Risk factors for mortality among human immunodeficiency virus-exposed and unexposed infants admitted to a neonatal intensive care unit in Botswana. Journal of Paediatrics and Child Health. 50: 189-95. PMID 24372811 DOI: 10.1111/Jpc.12454  0.382
2014 Sollerkvist LP, Gaseitsiwe S, Mine M, Sebetso G, Mphoyakgosi T, Diphoko T, Essex M, Ehrnst A. Increased CXCR4 use of HIV-1 subtype C identified by population sequencing in patients failing antiretroviral treatment compared with treatment-naive patients in Botswana. Aids Research and Human Retroviruses. 30: 436-45. PMID 24205895 DOI: 10.1089/AID.2013.0203  0.384
2014 Moyo S, LeCuyer T, Wang R, Gaseitsiwe S, Weng J, Musonda R, Bussmann H, Mine M, Engelbrecht S, Makhema J, Marlink R, Baum MK, Novitsky V, Essex M. Evaluation of the false recent classification rates of multiassay algorithms in estimating HIV type 1 subtype C incidence. Aids Research and Human Retroviruses. 30: 29-36. PMID 23937344 DOI: 10.1089/AID.2013.0055  0.453
2014 Anderson M, Gaseitsiwe S, Moyo S, Mohammed T, Sebunya TK, Blackard J, Makhema J, Essex M, Musonda R. Prevalence and molecular characterization of Hepatitis B in HIV infected individuals in Botswana Bmc Infectious Diseases. 14. DOI: 10.1186/1471-2334-14-S2-P86  0.719
2014 Essex M. 140 Reversing the Epidemic of HIV-1C in Southern Africa with Treatment as Prevention Jaids Journal of Acquired Immune Deficiency Syndromes. 65: 59. DOI: 10.1097/01.qai.0000446720.60423.1e  0.438
2013 Shapiro RL, Kitch D, Ogwu A, Hughes MD, Lockman S, Powis K, Souda S, Moffat C, Moyo S, McIntosh K, van Widenfelt E, Zwerski S, Mazhani L, Makhema J, Essex M. HIV transmission and 24-month survival in a randomized trial of HAART to prevent MTCT during pregnancy and breastfeeding in Botswana. Aids (London, England). 27: 1911-20. PMID 24180000 DOI: 10.1097/Qad.0B013E32836158B0  0.478
2013 Dryden-Peterson S, Jayeoba O, Hughes MD, Jibril H, McIntosh K, Modise TA, Asmelash A, Powis KM, Essex M, Shapiro RL, Lockman S. Cotrimoxazole prophylaxis and risk of severe anemia or severe neutropenia in HAART-exposed, HIV-uninfected infants. Plos One. 8: e74171. PMID 24086319 DOI: 10.1371/Journal.Pone.0074171  0.482
2013 Kiwelu IE, Novitsky V, Margolin L, Baca J, Manongi R, Sam N, Shao J, McLane MF, Kapiga SH, Essex M. Frequent intra-subtype recombination among HIV-1 circulating in Tanzania. Plos One. 8: e71131. PMID 23940702 DOI: 10.1371/journal.pone.0071131  0.502
2013 McDonald B, Moyo S, Gabaitiri L, Gaseitsiwe S, Bussmann H, Koethe JR, Musonda R, Makhema J, Novitsky V, Marlink RG, Wester CW, Essex M. Persistently elevated serum interleukin-6 predicts mortality among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial. Aids Research and Human Retroviruses. 29: 993-9. PMID 23590237 DOI: 10.1089/Aid.2012.0309  0.42
2013 Souda S, Gaseitsiwe S, Georgette N, Powis K, Moremedi D, Iketleng T, Leidner J, Moffat C, Ogwu A, Lockman S, Moyo S, Mmalane M, Musonda R, Makhema J, Essex M, et al. No clinically significant drug-resistance mutations in HIV-1 subtype C-infected women after discontinuation of NRTI-based or PI-based HAART for PMTCT in Botswana. Journal of Acquired Immune Deficiency Syndromes (1999). 63: 572-7. PMID 23542639 DOI: 10.1097/Qai.0B013E31829308F8  0.48
2013 Wang R, Weng J, Moyo S, Pain D, Barr CD, Maruapula D, Mongwato D, Makhema J, Novitsky V, Essex M. Short communication: effect of short-course antenatal zidovudine and single-dose nevirapine on the BED capture enzyme immunoassay levels in HIV type 1 subtype C infection. Aids Research and Human Retroviruses. 29: 901-6. PMID 23521375 DOI: 10.1089/AID.2012.0294  0.392
2013 Rossenkhan R, MacLeod IJ, Sebunya TK, Castro-Nallar E, McLane MF, Musonda R, Gashe BA, Novitsky V, Essex M. tat Exon 1 exhibits functional diversity during HIV-1 subtype C primary infection. Journal of Virology. 87: 5732-45. PMID 23487450 DOI: 10.1128/JVI.03297-12  0.503
2013 Finucane MM, Rowley CF, Paciorek CJ, Essex M, Pagano M. Estimating the prevalence of transmitted HIV drug resistance using pooled samples. Statistical Methods in Medical Research. PMID 23376965 DOI: 10.1177/0962280212473514  0.357
2013 Powis KM, McElrath TF, Hughes MD, Ogwu A, Souda S, Datwyler SA, von Widenfelt E, Moyo S, Nádas M, Makhema J, Machakaire E, Lockman S, Essex M, Shapiro RL. High viral load and elevated angiogenic markers associated with increased risk of preeclampsia among women initiating highly active antiretroviral therapy in pregnancy in the Mma Bana study, Botswana. Journal of Acquired Immune Deficiency Syndromes (1999). 62: 517-24. PMID 23344545 DOI: 10.1097/Qai.0B013E318286D77E  0.46
2013 Retshabile G, Kisanga ER, Gaseitsiwe S, Moyo SM, Bussmann H, Makhema J, Essex M, Marlink R, Musonda R. O15.1 Sub-Optimal CD4 T-Cell Recovery in HIV-1 Subtype C Patients on Antiretroviral Therapy: A Search For Predictive Biomarkers and Baseline Characteristics Sexually Transmitted Infections. 89: A54.3-A55. DOI: 10.1136/sextrans-2013-051184.0167  0.307
2013 Essex M, Novitsky V. Prevention of HIV infection in the absence of a vaccine Hiv/Aids Treatment in Resource Poor Countries: Public Health Challenges. 1-10. DOI: 10.1007/978-1-4614-4520-3_1  0.476
2013 Lu Y, Essex M, Chanyasulkit C. HIV/AIDS treatment in resource poor countries: Public health challenges Hiv/Aids Treatment in Resource Poor Countries: Public Health Challenges. 1-98. DOI: 10.1007/978-1-4614-4520-3  0.302
2012 Mine M, Moyo S, Stevens P, Michael K, Novitsky V, Makhaola K, Asmelash A, Molefhabangwe S, Woldegabriel E, Mothowaeng G, Maruta T, Kamhukamwe C, Mangwendeza PM, Holmes-Pretorius M, Mtoni I, ... ... Essex M, et al. Immunohaematological reference values for HIV-negative healthy adults in Botswana. African Journal of Laboratory Medicine. 1: 5. PMID 29062725 DOI: 10.4102/ajlm.v1i1.5  0.319
2012 Mine M, Moyo S, Stevens P, Michael K, Novitsky V, Makhaola K, Asmelash A, Molefhabangwe S, Woldegabriel E, Mothowaeng G, Maruta T, Kamhukamwe C, Mangwendeza PM, Holmes-Pretorius M, Mtoni I, ... ... Essex M, et al. Immunohaematological reference values for HIV-negative healthy adults in Botswana. African Journal of Laboratory Medicine. 1. PMID 23772402  0.387
2012 Kiwelu IE, Novitsky V, Margolin L, Baca J, Manongi R, Sam N, Shao J, McLane MF, Kapiga SH, Essex M. HIV-1 subtypes and recombinants in Northern Tanzania: distribution of viral quasispecies. Plos One. 7: e47605. PMID 23118882 DOI: 10.1371/journal.pone.0047605  0.511
2012 Chen JY, Ribaudo HJ, Souda S, Parekh N, Ogwu A, Lockman S, Powis K, Dryden-Peterson S, Creek T, Jimbo W, Madidimalo T, Makhema J, Essex M, Shapiro RL. Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana. The Journal of Infectious Diseases. 206: 1695-705. PMID 23066160 DOI: 10.1093/Infdis/Jis553  0.403
2012 Mackelprang RD, Baeten JM, Donnell D, Celum C, Farquhar C, de Bruyn G, Essex M, McElrath MJ, Nakku-Joloba E, Lingappa JR. Quantifying ongoing HIV-1 exposure in HIV-1-serodiscordant couples to identify individuals with potential host resistance to HIV-1. The Journal of Infectious Diseases. 206: 1299-308. PMID 22926009 DOI: 10.1093/Infdis/Jis480  0.57
2012 MacLeod IJ, Rowley CF, Lockman S, Ogwu A, Moyo S, van Widenfelt E, Mmalane M, Makhema J, Essex M, Shapiro RL. Abacavir alters the transcription of inflammatory cytokines in virologically suppressed, HIV-infected women. Journal of the International Aids Society. 15: 17393. PMID 22789611 DOI: 10.7448/IAS.15.2.17393  0.4
2012 Padian NS, Isbell MT, Russell ES, Essex M. The future of HIV prevention. Journal of Acquired Immune Deficiency Syndromes (1999). 60: S22-6. PMID 22772385 DOI: 10.1097/Qai.0B013E31825B7100  0.544
2012 Shapiro RL, Souda S, Parekh N, Binda K, Kayembe M, Lockman S, Svab P, Babitseng O, Powis K, Jimbo W, Creek T, Makhema J, Essex M, Roberts DJ. High prevalence of hypertension and placental insufficiency, but no in utero HIV transmission, among women on HAART with stillbirths in Botswana. Plos One. 7: e31580. PMID 22384039 DOI: 10.1371/Journal.Pone.0031580  0.552
2012 Becquet R, Marston M, Dabis F, Moulton LH, Gray G, Coovadia HM, Essex M, Ekouevi DK, Jackson D, Coutsoudis A, Kilewo C, Leroy V, Wiktor SZ, Nduati R, Msellati P, et al. Children who acquire HIV infection perinatally are at higher risk of early death than those acquiring infection through breastmilk: a meta-analysis. Plos One. 7: e28510. PMID 22383946 DOI: 10.1371/Journal.Pone.0028510  0.432
2012 Laeyendecker O, Brookmeyer R, Mullis CE, Donnell D, Lingappa J, Celum C, Baeten JM, Campbell MS, Essex M, de Bruyn G, Farquhar C, Quinn TC, Eshleman SH. Specificity of four laboratory approaches for cross-sectional HIV incidence determination: analysis of samples from adults with known nonrecent HIV infection from five African countries. Aids Research and Human Retroviruses. 28: 1177-83. PMID 22283149 DOI: 10.1089/Aid.2011.0341  0.442
2012 Novitsky V, Essex M. Using HIV viral load to guide treatment-for-prevention interventions. Current Opinion in Hiv and Aids. 7: 117-24. PMID 22258501 DOI: 10.1097/Coh.0B013E32834Fe8Ff  0.503
2012 Shapiro RL, Souda S, Parekh N, Kayembe M, Svab P, Powis K, Jimbo W, Makhema J, Essex M, Roberts DJ. High prevalence of chronic placental hypertensive damage, but no in utero HIV transmission, among women on HAART who deliver stillbirths in Botswana F1000research. 3. DOI: 10.7490/F1000Research.1089974.1  0.463
2012 Kiwelu I, Novitsky V, Margolin L, Baca J, Manongi R, Sam N, Shao J, MacLane M, Kapiga S, Essex M. Analysis of HIV-1 gp120 quasispecies suggests high prevalence of intra-subtype recombination Retrovirology. 9. DOI: 10.1186/1742-4690-9-S2-P146  0.448
2012 Rossenkhan R, Novitsky V, Sebunya T, Musonda R, Gashe B, Essex M. Evolutionary dynamics of HIV-1 subtype C accessory and regulatory genes in primary infection Retrovirology. 9. DOI: 10.1186/1742-4690-9-S2-P142  0.405
2012 Novitsky VA, Essex M. HIV replication Hiv and Liver Disease. 91-99. DOI: 10.1007/9781441917126_10  0.446
2011 Matthews LT, Ribaudo HJ, Parekh NK, Chen JY, Binda K, Ogwu A, Makhema J, Souda S, Lockman S, Essex M, Shapiro RL. Birth weight for gestational age norms for a large cohort of infants born to HIV-negative women in Botswana compared with norms for U.S.-born black infants. Bmc Pediatrics. 11: 115. PMID 22176889 DOI: 10.1186/1471-2431-11-115  0.413
2011 Lingappa JR, Petrovski S, Kahle E, Fellay J, Shianna K, McElrath MJ, Thomas KK, Baeten JM, Celum C, Wald A, de Bruyn G, Mullins JI, Nakku-Joloba E, Farquhar C, Essex M, et al. Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure. Plos One. 6: e28632. PMID 22174851 DOI: 10.1371/Journal.Pone.0028632  0.575
2011 Novitsky V, Wang R, Baca J, Margolin L, McLane MF, Moyo S, van Widenfelt E, Makhema J, Essex M. Evolutionary gamut of in vivo Gag substitutions during early HIV-1 subtype C infection. Virology. 421: 119-28. PMID 22014506 DOI: 10.1016/j.virol.2011.09.020  0.477
2011 Dryden-Peterson S, Jayeoba O, Hughes MD, Jibril H, Keapoletswe K, Tlale J, Modise TA, Asmelash A, Moyo S, van Widenfelt E, Makhema J, Essex M, Shapiro RL, Lockman S. Highly active antiretroviral therapy versus zidovudine for prevention of mother-to-child transmission in a programmatic setting, Botswana. Journal of Acquired Immune Deficiency Syndromes (1999). 58: 353-7. PMID 21792062 DOI: 10.1097/Qai.0B013E31822D4063  0.378
2011 Powis KM, Kitch D, Ogwu A, Hughes MD, Lockman S, Leidner J, van Widenfelt E, Moffat C, Moyo S, Makhema J, Essex M, Shapiro RL. Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy. The Journal of Infectious Diseases. 204: 506-14. PMID 21791651 DOI: 10.1093/infdis/jir307  0.419
2011 Parekh N, Ribaudo H, Souda S, Chen J, Mmalane M, Powis K, Essex M, Makhema J, Shapiro RL. Risk factors for very preterm delivery and delivery of very-small-for-gestational-age infants among HIV-exposed and HIV-unexposed infants in Botswana. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. 115: 20-5. PMID 21767835 DOI: 10.1016/J.Ijgo.2011.04.008  0.467
2011 Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Mehendale S, Chariyalertsak S, Santos BR, Mayer KH, ... ... Essex M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. The New England Journal of Medicine. 365: 493-505. PMID 21767103 DOI: 10.1056/Nejmoa1105243  0.483
2011 Novitsky V, Ndung'u T, Wang R, Bussmann H, Chonco F, Makhema J, De Gruttola V, Walker BD, Essex M. Extended high viremics: a substantial fraction of individuals maintain high plasma viral RNA levels after acute HIV-1 subtype C infection. Aids (London, England). 25: 1515-22. PMID 21505307 DOI: 10.1097/QAD.0b013e3283471eb2  0.448
2011 Novitsky V, Wang R, Margolin L, Baca J, Rossenkhan R, Moyo S, van Widenfelt E, Essex M. Transmission of single and multiple viral variants in primary HIV-1 subtype C infection. Plos One. 6: e16714. PMID 21415914 DOI: 10.1371/Journal.Pone.0016714  0.564
2011 Armstrong KL, Lee TH, Essex M. Replicative fitness costs of nonnucleoside reverse transcriptase inhibitor drug resistance mutations on HIV subtype C. Antimicrobial Agents and Chemotherapy. 55: 2146-53. PMID 21402856 DOI: 10.1128/AAC.01505-10  0.643
2011 Gilbert PB, Berger JO, Stablein D, Becker S, Essex M, Hammer SM, Kim JH, Degruttola VG. Statistical interpretation of the RV144 HIV vaccine efficacy trial in Thailand: a case study for statistical issues in efficacy trials. The Journal of Infectious Diseases. 203: 969-75. PMID 21402548 DOI: 10.1093/Infdis/Jiq152  0.405
2011 Wright JK, Novitsky V, Brockman MA, Brumme ZL, Brumme CJ, Carlson JM, Heckerman D, Wang B, Losina E, Leshwedi M, van der Stok M, Maphumulo L, Mkhwanazi N, Chonco F, Goulder PJ, ... Essex M, et al. Influence of Gag-protease-mediated replication capacity on disease progression in individuals recently infected with HIV-1 subtype C. Journal of Virology. 85: 3996-4006. PMID 21289112 DOI: 10.1128/Jvi.02520-10  0.389
2011 Dryden-Peterson S, Shapiro RL, Hughes MD, Powis K, Ogwu A, Moffat C, Moyo S, Makhema J, Essex M, Lockman S. Increased risk of severe infant anemia after exposure to maternal HAART, Botswana. Journal of Acquired Immune Deficiency Syndromes (1999). 56: 428-36. PMID 21266910 DOI: 10.1097/Qai.0B013E31820Bd2B6  0.389
2011 Marston M, Becquet R, Zaba B, Moulton LH, Gray G, Coovadia H, Essex M, Ekouevi DK, Jackson D, Coutsoudis A, Kilewo C, Leroy V, Wiktor S, Nduati R, Msellati P, et al. Net survival of perinatally and postnatally HIV-infected children: a pooled analysis of individual data from sub-Saharan Africa. International Journal of Epidemiology. 40: 385-96. PMID 21247884 DOI: 10.1093/Ije/Dyq255  0.487
2011 Powis KM, Smeaton L, Ogwu A, Lockman S, Dryden-Peterson S, van Widenfelt E, Leidner J, Makhema J, Essex M, Shapiro RL. Effects of in utero antiretroviral exposure on longitudinal growth of HIV-exposed uninfected infants in Botswana. Journal of Acquired Immune Deficiency Syndromes (1999). 56: 131-8. PMID 21124227 DOI: 10.1097/Qai.0B013E3181Ffa4F5  0.472
2011 Bussmann H, de la Hoz Gomez F, Roels TH, Wester CW, Bodika SM, Moyo S, Taffa N, Anderson MG, Mine M, Bile EC, Yang C, Mphoyakgosi K, Lehotzky EA, Mlotshwa B, Mmelesi M, ... ... Essex M, et al. Prevalence of transmitted HIV drug resistance in Botswana: lessons learned from the HIVDR-Threshold Survey conducted among women presenting for routine antenatal care as part of the 2007 national sentinel survey. Aids Research and Human Retroviruses. 27: 365-72. PMID 21034246 DOI: 10.1089/Aid.2009.0299  0.487
2011 Essex M. 108 HIV-1C of Southern Africa: Why Is the Virus More Fit? Jaids Journal of Acquired Immune Deficiency Syndromes. 56: 43. DOI: 10.1097/01.Qai.0000397298.18174.A9  0.577
2010 Novitsky V, Wang R, Lagakos S, Essex M. HIV-1 Subtype C Phylodynamics in the Global Epidemic. Viruses. 2: 33-54. PMID 21994599 DOI: 10.3390/V2010033  0.459
2010 Shapiro RL, Hughes MD, Ogwu A, Kitch D, Lockman S, Moffat C, Makhema J, Moyo S, Thior I, McIntosh K, van Widenfelt E, Leidner J, Powis K, Asmelash A, Tumbare E, ... ... Essex M, et al. Antiretroviral regimens in pregnancy and breast-feeding in Botswana. The New England Journal of Medicine. 362: 2282-94. PMID 20554983 DOI: 10.1056/Nejmoa0907736  0.44
2010 Novitsky V, Wang R, Margolin L, Baca J, Moyo S, Musonda R, Essex M. Dynamics and timing of in vivo mutations at Gag residue 242 during primary HIV-1 subtype C infection. Virology. 403: 37-46. PMID 20444482 DOI: 10.1016/J.Virol.2010.04.001  0.423
2010 MacLeod IJ, Rowley CF, Thior I, Wester C, Makhema J, Essex M, Lockman S. Minor resistant variants in nevirapine-exposed infants may predict virologic failure on nevirapine-containing ART. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 48: 162-7. PMID 20427228 DOI: 10.1016/J.Jcv.2010.03.017  0.374
2010 Teeravechyan S, Essex M, Lee TH. Conserved determinants of enhanced CCR5 binding in the human immunodeficiency virus subtype D envelope third variable loop. Aids Research and Human Retroviruses. 26: 481-8. PMID 20377425 DOI: 10.1089/Aid.2009.0086  0.458
2010 Rowley CF, Boutwell CL, Lee EJ, MacLeod IJ, Ribaudo HJ, Essex M, Lockman S. Ultrasensitive detection of minor drug-resistant variants for HIV after nevirapine exposure using allele-specific PCR: clinical significance. Aids Research and Human Retroviruses. 26: 293-300. PMID 20334564 DOI: 10.1089/Aid.2009.0082  0.391
2010 Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, Mugo N, Mujugira A, Baeten JM, Mullins JI, Hughes JP, Bukusi EA, Cohen CR, Katabira E, Ronald A, Kiarie J, ... ... Essex M, et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. The New England Journal of Medicine. 362: 427-39. PMID 20089951 DOI: 10.1056/Nejmoa0904849  0.518
2010 Chen JY, Ogwu AC, Svab P, Lockman S, Moffat HJ, Gaolathe T, Moilwa S, Størdal K, Dryden-Peterson S, Moffat C, Makhema J, Essex M, Shapiro RL. Antiretroviral treatment initiation among HIV-infected pregnant women with low CD4(+) cell counts in Gaborone, Botswana. Journal of Acquired Immune Deficiency Syndromes (1999). 54: 102-6. PMID 19864957 DOI: 10.1097/Qai.0B013E3181C080Bf  0.42
2010 Kebaabetswe P, Ndase P, Mujugira A, Sekoto T, Ntshimane M, Owor A, Makhema J, Thior I, Essex M. Perceptions of couple HIV counseling and testing in Botswana: a stakeholder analysis. Patient Education and Counseling. 79: 120-3. PMID 19682831 DOI: 10.1016/J.Pec.2009.07.017  0.437
2009 Wester CW, Bussmann H, Koethe J, Moffat C, Vermund S, Essex M, Marlink RG. Adult combination antiretroviral therapy in sub-Saharan Africa: lessons from Botswana and future challenges. Hiv Therapy. 3: 501-526. PMID 20161344 DOI: 10.2217/Hiv.09.35  0.421
2009 Rossenkhan R, Ndung'u T, Sebunya TK, Hagan JE, Shapiro R, Novitsky V, Moyo SM, Thior I, Lockman S, Mitchell R, Kim S, Musonda R, van Widenfelt E, Makhema J, Essex M. Temporal reduction of HIV type 1 viral load in breast milk by single-dose nevirapine during prevention of MTCT. Aids Research and Human Retroviruses. 25: 1261-4. PMID 20001515 DOI: 10.1089/Aid.2009.0037  0.465
2009 Doualla-Bell F, Gaolathe T, Avalos A, Cloutier S, Ndwapi N, Holcroft C, Moffat H, Dickinson D, Essex M, Wainberg MA, Mine M. Five-year follow up of genotypic resistance patterns in HIV-1 subtype C infected patients in Botswana after failure of thymidine analogue-based regimens. Journal of the International Aids Society. 12: 25. PMID 19852859 DOI: 10.1186/1758-2652-12-25  0.408
2009 Novitsky V, Wang R, Kebaabetswe L, Greenwald J, Rossenkhan R, Moyo S, Musonda R, Woldegabriel E, Lagakos S, Essex M. Better control of early viral replication is associated with slower rate of elicited antiviral antibodies in the detuned enzyme immunoassay during primary HIV-1C infection. Journal of Acquired Immune Deficiency Syndromes (1999). 52: 265-72. PMID 19525854 DOI: 10.1097/Qai.0B013E3181Ab6Ef0  0.535
2009 Mine M, Bedi K, Maruta T, Madziva D, Tau M, Zana T, Gaolathe T, Moyo S, Seipone K, Ndwapi N, Essex M, Marlink R. Quantitation of human immunodeficiency virus type 1 viral load in plasma using reverse transcriptase activity assay at a district hospital laboratory in Botswana: a decentralization pilot study. Journal of Virological Methods. 159: 93-7. PMID 19442851 DOI: 10.1016/J.Jviromet.2009.03.008  0.428
2009 Novitsky V, Woldegabriel E, Kebaabetswe L, Rossenkhan R, Mlotshwa B, Bonney C, Finucane M, Musonda R, Moyo S, Wester C, van Widenfelt E, Makhema J, Lagakos S, Essex M. Viral load and CD4+ T-cell dynamics in primary HIV-1 subtype C infection. Journal of Acquired Immune Deficiency Syndromes (1999). 50: 65-76. PMID 19295336 DOI: 10.1097/Qai.0B013E3181900141  0.475
2009 Bussmann H, Wester CW, Thomas A, Novitsky V, Okezie R, Muzenda T, Gaolathe T, Ndwapi N, Mawoko N, Widenfelt E, Moyo S, Musonda R, Mine M, Makhema J, Moffat H, ... Essex M, et al. Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial. Journal of Acquired Immune Deficiency Syndromes (1999). 51: 37-46. PMID 19282782 DOI: 10.1097/Qai.0B013E31819Ff102  0.476
2009 Armstrong KL, Lee TH, Essex M. Replicative capacity differences of thymidine analog resistance mutations in subtype B and C human immunodeficiency virus type 1. Journal of Virology. 83: 4051-9. PMID 19225005 DOI: 10.1128/Jvi.02645-08  0.66
2009 Shapiro RL, Smeaton L, Lockman S, Thior I, Rossenkhan R, Wester C, Stevens L, Moffat C, Arimi P, Ndase P, Asmelash A, Leidner J, Novitsky V, Makhema J, Essex M. Risk factors for early and late transmission of HIV via breast-feeding among infants born to HIV-infected women in a randomized clinical trial in Botswana. The Journal of Infectious Diseases. 199: 414-8. PMID 19090775 DOI: 10.1086/596034  0.432
2009 Novitsky V, Lagakos S, Herzig M, Bonney C, Kebaabetswe L, Rossenkhan R, Nkwe D, Margolin L, Musonda R, Moyo S, Woldegabriel E, van Widenfelt E, Makhema J, Essex M. Evolution of proviral gp120 over the first year of HIV-1 subtype C infection. Virology. 383: 47-59. PMID 18973914 DOI: 10.1016/J.Virol.2008.09.017  0.49
2009 Lingappa J, Hughes J, Donnel D, Baeten J, Mullins J, Campbell M, Gray G, Essex M, Farquhar C, Rees H, Wald A, Corey L, Celum C. OA01-06 LB. HIV-1 plasma RNA and risk of HIV-1 transmission Retrovirology. 6: O12. DOI: 10.1186/1742-4690-6-S3-O12  0.446
2008 Chigwedere P, Seage GR, Gruskin S, Lee TH, Essex M. Estimating the lost benefits of antiretroviral drug use in South Africa. Journal of Acquired Immune Deficiency Syndromes (1999). 49: 410-5. PMID 19186354 DOI: 10.1097/Qai.0B013E31818A6Cd5  0.499
2008 Novitsky V, Woldegabriel E, Wester C, McDonald E, Rossenkhan R, Ketunuti M, Makhema J, Seage GR, Essex M. Identification of primary HIV-1C infection in Botswana. Aids Care. 20: 806-11. PMID 18608056 DOI: 10.1080/09540120701694055  0.496
2008 Chigwedere P, Seage GR, Lee TH, Essex M. Efficacy of antiretroviral drugs in reducing mother-to-child transmission of HIV in Africa: a meta-analysis of published clinical trials. Aids Research and Human Retroviruses. 24: 827-37. PMID 18544018 DOI: 10.1089/Aid.2007.0291  0.48
2008 Rowley CF, Boutwell CL, Lockman S, Essex M. Improvement in allele-specific PCR assay with the use of polymorphism-specific primers for the analysis of minor variant drug resistance in HIV-1 subtype C. Journal of Virological Methods. 149: 69-75. PMID 18295909 DOI: 10.1016/j.jviromet.2008.01.005  0.326
2008 Teeravechyan S, Suphaphiphat P, Essex M, Lee TH. Relative concordance of human immunodeficiency virus oligomeric and monomeric envelope in CCR5 coreceptor usage. Virology. 370: 443-50. PMID 17936869 DOI: 10.1016/J.Virol.2007.09.009  0.394
2008 Essex M. AIDS: Overview International Encyclopedia of Public Health. 90-98. DOI: 10.1016/B978-012373960-5.00455-X  0.345
2008 Essex M, Lu Y. HIV/AIDS: Lessons from a new disease pandemic Emerging Infections in Asia. 133-142. DOI: 10.1007/978-0-387-75722-3_8  0.362
2007 Redd AD, Avalos A, Phiri K, Essex M. Effects of HIV type 1 infection on hematopoiesis in Botswana. Aids Research and Human Retroviruses. 23: 996-1003. PMID 17725416 DOI: 10.1089/Aid.2006.0283  0.517
2007 Redd AD, Avalos A, Essex M. Infection of hematopoietic progenitor cells by HIV-1 subtype C, and its association with anemia in southern Africa. Blood. 110: 3143-9. PMID 17693583 DOI: 10.1182/Blood-2007-04-086314  0.594
2007 Novitsky V, Gaolathe T, Woldegabriel E, Makhema J, Essex M. A seronegative case of HIV-1 subtype C infection in Botswana. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 45: e68-71. PMID 17682982 DOI: 10.1086/520683  0.51
2007 Novitsky V, Wester CW, DeGruttola V, Bussmann H, Gaseitsiwe S, Thomas A, Moyo S, Musonda R, Van Widenfelt E, Marlink RG, Essex M. The reverse transcriptase 67N 70R 215Y genotype is the predominant TAM pathway associated with virologic failure among HIV type 1C-infected adults treated with ZDV/ddI-containing HAART in southern Africa. Aids Research and Human Retroviruses. 23: 868-78. PMID 17678469 DOI: 10.1089/Aid.2006.0298  0.538
2007 Shapiro RL, Lockman S, Kim S, Smeaton L, Rahkola JT, Thior I, Wester C, Moffat C, Arimi P, Ndase P, Asmelash A, Stevens L, Montano M, Makhema J, Essex M, et al. Infant morbidity, mortality, and breast milk immunologic profiles among breast-feeding HIV-infected and HIV-uninfected women in Botswana. The Journal of Infectious Diseases. 196: 562-9. PMID 17624842 DOI: 10.1086/519847  0.528
2007 Bussmann H, Wester CW, Wester CN, Lekoko B, Okezie O, Thomas AM, DeGruttola SM, Makhema J, Essex M, Marlink RG. Pregnancy rates and birth outcomes among women on efavirenz-containing highly active antiretroviral therapy in Botswana. Journal of Acquired Immune Deficiency Syndromes (1999). 45: 269-73. PMID 17450102 DOI: 10.1097/Qai.0B013E318050D683  0.374
2007 Kapiga SH, Sam NE, Bang H, Ni Q, Ao TT, Kiwelu I, Chiduo S, Ndibe U, Seage G, Coplan P, Shao J, Rosenberg ZF, Essex M. The role of herpes simplex virus type 2 and other genital infections in the acquisition of HIV-1 among high-risk women in northern Tanzania. The Journal of Infectious Diseases. 195: 1260-9. PMID 17396994 DOI: 10.1086/513566  0.543
2007 Trujillo JR, Rogers R, Molina RM, Dangond F, McLane MF, Essex M, Brain JD. Noninfectious entry of HIV-1 into peripheral and brain macrophages mediated by the mannose receptor. Proceedings of the National Academy of Sciences of the United States of America. 104: 5097-102. PMID 17360361 DOI: 10.1073/Pnas.0611263104  0.554
2007 Boutwell CL, Essex M. Identification of HLA class I-associated amino acid polymorphisms in the HIV-1C proteome. Aids Research and Human Retroviruses. 23: 165-74. PMID 17263647 DOI: 10.1089/Aid.2006.0131  0.489
2007 Tassiopoulos KK, Seage G, Sam N, Kiwelu I, Shao J, Ao TT, Essex M, Coplan P, Rosenberg Z, Hughes M, Kapiga S. Predictors of herpes simplex virus type 2 prevalence and incidence among bar and hotel workers in Moshi, Tanzania. The Journal of Infectious Diseases. 195: 493-501. PMID 17230408 DOI: 10.1086/510537  0.534
2007 Lockman S, Shapiro RL, Smeaton LM, Wester C, Thior I, Stevens L, Chand F, Makhema J, Moffat C, Asmelash A, Ndase P, Arimi P, van Widenfelt E, Mazhani L, Novitsky V, ... ... Essex M, et al. Response to antiretroviral therapy after a single, peripartum dose of nevirapine. The New England Journal of Medicine. 356: 135-47. PMID 17215531 DOI: 10.1056/Nejmoa062876  0.43
2007 Suphaphiphat P, Essex M, Lee TH. Mutations in the V3 stem versus the V3 crown and C4 region have different effects on the binding and fusion steps of human immunodeficiency virus type 1 gp120 interaction with the CCR5 coreceptor. Virology. 360: 182-90. PMID 17101166 DOI: 10.1016/J.Virol.2006.10.019  0.353
2006 Wester CW, Bussmann H, Moyo S, Avalos A, Gaolathe T, Ndwapi N, Essex M, MacGregor RR, Marlink RG. Serological evidence of HIV-associated infection among HIV-1-infected adults in Botswana. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 43: 1612-5. PMID 17109297 DOI: 10.1086/508865  0.535
2006 Doualla-Bell F, Avalos A, Brenner B, Gaolathe T, Mine M, Gaseitsiwe S, Oliveira M, Moisi D, Ndwapi N, Moffat H, Essex M, Wainberg MA. High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens. Antimicrobial Agents and Chemotherapy. 50: 4182-5. PMID 17015626 DOI: 10.1128/Aac.00714-06  0.399
2006 Thior I, Lockman S, Smeaton LM, Shapiro RL, Wester C, Heymann SJ, Gilbert PB, Stevens L, Peter T, Kim S, van Widenfelt E, Moffat C, Ndase P, Arimi P, Kebaabetswe P, ... ... Essex M, et al. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. Jama. 296: 794-805. PMID 16905785 DOI: 10.1001/Jama.296.7.794  0.481
2006 Shapiro RL, Thior I, Gilbert PB, Lockman S, Wester C, Smeaton LM, Stevens L, Heymann SJ, Ndung'u T, Gaseitsiwe S, Novitsky V, Makhema J, Lagakos S, Essex M. Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana. Aids (London, England). 20: 1281-8. PMID 16816557 DOI: 10.1097/01.Aids.0000232236.26630.35  0.453
2006 Brenner BG, Oliveira M, Doualla-Bell F, Moisi DD, Ntemgwa M, Frankel F, Essex M, Wainberg MA. HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture. Aids (London, England). 20: F9-13. PMID 16816549 DOI: 10.1097/01.Aids.0000232228.88511.0B  0.476
2006 Doualla-Bell F, Avalos A, Gaolathe T, Mine M, Gaseitsiwe S, Ndwapi N, Novitsky VA, Brenner B, Oliveira M, Moisi D, Moffat H, Thior I, Essex M, Wainberg MA. Impact of human immunodeficiency virus type 1 subtype C on drug resistance mutations in patients from Botswana failing a nelfinavir-containing regimen. Antimicrobial Agents and Chemotherapy. 50: 2210-3. PMID 16723586 DOI: 10.1128/Aac.01447-05  0.394
2006 Montano M, Rarick M, Sebastiani P, Brinkmann P, Russell M, Navis A, Wester C, Thior I, Essex M. Gene-expression profiling of HIV-1 infection and perinatal transmission in Botswana. Genes and Immunity. 7: 298-309. PMID 16691187 DOI: 10.1038/Sj.Gene.6364297  0.477
2006 Koulinska IN, Villamor E, Msamanga G, Fawzi W, Blackard J, Renjifo B, Essex M. Risk of HIV-1 transmission by breastfeeding among mothers infected with recombinant and non-recombinant HIV-1 genotypes. Virus Research. 120: 191-8. PMID 16621098 DOI: 10.1016/J.Virusres.2006.03.007  0.734
2006 Vasan A, Renjifo B, Hertzmark E, Chaplin B, Msamanga G, Essex M, Fawzi W, Hunter D. Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 42: 843-52. PMID 16477563 DOI: 10.1086/499952  0.589
2006 Paca-Uccaralertkun S, Damgaard CK, Auewarakul P, Thitithanyanont A, Suphaphiphat P, Essex M, Kjems J, Lee TH. The Effect of a Single Nucleotide Substitution in the Splicing Silencer in the tat/rev Intron on HIV Type 1 Envelope Expression. Aids Research and Human Retroviruses. 22: 76-82. PMID 16438649 DOI: 10.1089/Aid.2006.22.76  0.507
2006 Ndung'u T, Sepako E, McLane MF, Chand F, Bedi K, Gaseitsiwe S, Doualla-Bell F, Peter T, Thior I, Moyo SM, Gilbert PB, Novitsky VA, Essex M. HIV-1 subtype C in vitro growth and coreceptor utilization. Virology. 347: 247-60. PMID 16406460 DOI: 10.1016/J.Virol.2005.11.047  0.583
2006 Koulinska IN, Villamor E, Chaplin B, Msamanga G, Fawzi W, Renjifo B, Essex M. Transmission of cell-free and cell-associated HIV-1 through breast-feeding. Journal of Acquired Immune Deficiency Syndromes (1999). 41: 93-9. PMID 16340480 DOI: 10.1097/01.Qai.0000179424.19413.24  0.512
2006 Nkolola JP, Essex M. Progress towards an HIV-1 subtype C vaccine. Vaccine. 24: 391-401. PMID 16139396 DOI: 10.1016/J.Vaccine.2005.08.007  0.553
2006 Wainberg MA, Doualla-Bell F, Gaolatte T, Mine M, Essex M, Brenner B. HIV-1 subtype C viruses rapidly develop K65R Retrovirology. 3. DOI: 10.1186/1742-4690-3-S1-S4  0.56
2006 Essex M. Genetic variation in HIV-1C: implications for prevention and treatment Retrovirology. 3. DOI: 10.1186/1742-4690-3-S1-S3  0.554
2005 Gilbert PB, Novitsky V, Essex M. Covariability of selected amino acid positions for HIV type 1 subtypes C and B. Aids Research and Human Retroviruses. 21: 1016-30. PMID 16379605 DOI: 10.1089/Aid.2005.21.1016  0.557
2005 Sharghi N, Bosch RJ, Mayer K, Essex M, Seage GR. The development and utility of a clinical algorithm to predict early HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes (1999). 40: 472-8. PMID 16280704 DOI: 10.1097/01.Qai.0000164246.49098.47  0.522
2005 Wester CW, Kim S, Bussmann H, Avalos A, Ndwapi N, Peter TF, Gaolathe T, Mujugira A, Busang L, Vanderwarker C, Cardiello P, Johnson O, Thior I, Mazonde P, Moffat H, ... Essex M, et al. Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana. Journal of Acquired Immune Deficiency Syndromes (1999). 40: 336-43. PMID 16249709 DOI: 10.1097/01.Qai.0000159668.80207.5B  0.411
2005 Kiwelu IE, Koulinska IN, Nkya WM, Shao J, Kapiga S, Essex M. Identification of CRF10_CD viruses among bar and hotel workers in Moshi, Northern Tanzania. Aids Research and Human Retroviruses. 21: 897-900. PMID 16225419 DOI: 10.1089/Aid.2005.21.897  0.399
2005 Ndung'u T, Gaseitsiwe S, Sepako E, Doualla-Bell F, Peter T, Kim S, Thior I, Novitsky VA, Essex M. Major histocompatibility complex class II (HLA-DRB and -DQB) allele frequencies in Botswana: association with human immunodeficiency virus type 1 infection. Clinical and Diagnostic Laboratory Immunology. 12: 1020-8. PMID 16148166 DOI: 10.1128/Cdli.12.9.1020-1028.2005  0.455
2005 Shapiro RL, Holland DT, Capparelli E, Lockman S, Thior I, Wester C, Stevens L, Peter T, Essex M, Connor JD, Mirochnick M. Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment. The Journal of Infectious Diseases. 192: 720-7. PMID 16088821 DOI: 10.1086/432483  0.373
2005 Shapiro RL, Ndung'u T, Lockman S, Smeaton LM, Thior I, Wester C, Stevens L, Sebetso G, Gaseitsiwe S, Peter T, Essex M. Highly active antiretroviral therapy started during pregnancy or postpartum suppresses HIV-1 RNA, but not DNA, in breast milk. The Journal of Infectious Diseases. 192: 713-9. PMID 16088820 DOI: 10.1086/432489  0.469
2005 Bussmann H, Novitsky V, Wester W, Peter T, Masupu K, Gabaitiri L, Kim S, Gaseitsiwe S, Ndungú T, Marlink R, Thior I, Essex M. HIV-1 subtype C drug-resistance background among ARV-naive adults in Botswana. Antiviral Chemistry & Chemotherapy. 16: 103-15. PMID 15889533 DOI: 10.1177/095632020501600203  0.555
2005 Kanki PJ, Essex ME. Virology The Aids Pandemic. 13-35. DOI: 10.1016/B978-012465271-2/50004-2  0.483
2004 Doualla-Bell F, Gaseitsiwe S, Ndungú T, Modukanele M, Peter T, Novitsky V, Ndwapi N, Tendani G, Avalos A, Wester W, Bussmann H, Cardiello P, Marlink R, Moffat H, Thior I, ... ... Essex M, et al. Mutations and polymorphisms associated with antiretroviral drugs in HIV-1C-infected African patients. Antiviral Chemistry & Chemotherapy. 15: 189-200. PMID 15457680 DOI: 10.1177/095632020401500402  0.498
2004 Bussmann H, Wester CW, Masupu KV, Peter T, Gaolekwe SM, Kim S, Reich AM, Ahn S, Wu Y, Thior I, Essex M, Marlink R. Low CD4+ T-lymphocyte values in human immunodeficiency virus-negative adults in Botswana. Clinical and Diagnostic Laboratory Immunology. 11: 930-5. PMID 15358655 DOI: 10.1128/Cdli.11.5.930-935.2004  0.418
2004 Renjifo B, Gilbert P, Chaplin B, Msamanga G, Mwakagile D, Fawzi W, Essex M. Preferential in-utero transmission of HIV-1 subtype C as compared to HIV-1 subtype A or D. Aids (London, England). 18: 1629-36. PMID 15280773 DOI: 10.1097/01.Aids.0000131392.68597.34  0.563
2004 Turner D, Brenner B, Moisi D, Detorio M, Cesaire R, Kurimura T, Mori H, Essex M, Maayan S, Wainberg MA. Nucleotide and amino acid polymorphisms at drug resistance sites in non-B-subtype variants of human immunodeficiency virus type 1. Antimicrobial Agents and Chemotherapy. 48: 2993-8. PMID 15273111 DOI: 10.1128/Aac.48.8.2993-2998.2004  0.404
2004 McKinney DM, Skvoretz R, Livingston BD, Wilson CC, Anders M, Chesnut RW, Sette A, Essex M, Novitsky V, Newman MJ. Recognition of variant HIV-1 epitopes from diverse viral subtypes by vaccine-induced CTL. Journal of Immunology (Baltimore, Md. : 1950). 173: 1941-50. PMID 15265928 DOI: 10.4049/Jimmunol.173.3.1941  0.518
2004 Fawzi WW, Msamanga GI, Spiegelman D, Wei R, Kapiga S, Villamor E, Mwakagile D, Mugusi F, Hertzmark E, Essex M, Hunter DJ. A randomized trial of multivitamin supplements and HIV disease progression and mortality. The New England Journal of Medicine. 351: 23-32. PMID 15229304 DOI: 10.1056/Nejmoa040541  0.541
2003 Koulinska IN, Chaplin B, Mwakagile D, Essex M, Renjifo B. Hypermutation of HIV type 1 genomes isolated from infants soon after vertical infection. Aids Research and Human Retroviruses. 19: 1115-23. PMID 14709248 DOI: 10.1089/088922203771881211  0.483
2003 Weiser S, Wolfe W, Bangsberg D, Thior I, Gilbert P, Makhema J, Kebaabetswe P, Dickenson D, Mompati K, Essex M, Marlink R. Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. Journal of Acquired Immune Deficiency Syndromes (1999). 34: 281-8. PMID 14600572 DOI: 10.1097/00126334-200311010-00004  0.502
2003 Quan Y, Brenner BG, Marlink RG, Essex M, Kurimura T, Wainberg MA. Drug resistance profiles of recombinant reverse transcriptases from human immunodeficiency virus type 1 subtypes A/E, B, and C. Aids Research and Human Retroviruses. 19: 743-53. PMID 14585205 DOI: 10.1089/088922203769232548  0.34
2003 Montano M, Russell M, Gilbert P, Thior I, Lockman S, Shapiro R, Chang SY, Lee TH, Essex M. Comparative prediction of perinatal human immunodeficiency virus type 1 transmission, using multiple virus load markers. The Journal of Infectious Diseases. 188: 406-13. PMID 12870122 DOI: 10.1086/376838  0.528
2003 Shapiro RL, Lockman S, Thior I, Stocking L, Kebaabetswe P, Wester C, Peter T, Marlink R, Essex M, Heymann SJ. Low adherence to recommended infant feeding strategies among HIV-infected women: results from the pilot phase of a randomized trial to prevent mother-to-child transmission in Botswana. Aids Education and Prevention : Official Publication of the International Society For Aids Education. 15: 221-30. PMID 12866834 DOI: 10.1521/Aeap.15.4.221.23830  0.335
2003 Kebaabetswe P, Lockman S, Mogwe S, Mandevu R, Thior I, Essex M, Shapiro RL. Male circumcision: an acceptable strategy for HIV prevention in Botswana. Sexually Transmitted Infections. 79: 214-9. PMID 12794204 DOI: 10.1136/sti.79.3.214  0.384
2003 Renjifo B, Chung M, Gilbert P, Mwakagile D, Msamanga G, Fawzi W, Essex M. In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes. Virology. 307: 278-82. PMID 12667797 DOI: 10.1016/S0042-6822(02)00066-1  0.577
2003 Kapiga SH, Sam NE, Shao JF, Masenga EJ, Renjifo B, Kiwelu IE, Manongi R, Fawzi WW, Essex M. Herpes simplex virus type 2 infection among bar and hotel workers in northern Tanzania: prevalence and risk factors. Sexually Transmitted Diseases. 30: 187-92. PMID 12616132 DOI: 10.1097/00007435-200303000-00001  0.366
2003 Suphaphiphat P, Thitithanyanont A, Paca-Uccaralertkun S, Essex M, Lee TH. Effect of amino acid substitution of the V3 and bridging sheet residues in human immunodeficiency virus type 1 subtype C gp120 on CCR5 utilization. Journal of Virology. 77: 3832-7. PMID 12610158 DOI: 10.1128/Jvi.77.6.3832-3837.2003  0.446
2003 Kiwelu IE, Renjifo B, Chaplin B, Sam N, Nkya WM, Shao J, Kapiga S, Essex M. HIV type 1 subtypes among bar and hotel workers in Moshi, Tanzania. Aids Research and Human Retroviruses. 19: 57-64. PMID 12596722 DOI: 10.1089/08892220360473970  0.577
2003 Novitsky V, Gilbert P, Peter T, McLane MF, Gaolekwe S, Rybak N, Thior I, Ndung'u T, Marlink R, Lee TH, Essex M. Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection. Journal of Virology. 77: 882-90. PMID 12502804 DOI: 10.1128/Jvi.77.2.882-890.2003  0.526
2002 Fawzi W, Msamanga G, Spiegelman D, Renjifo B, Bang H, Kapiga S, Coley J, Hertzmark E, Essex M, Hunter D. Transmission of HIV-1 through breastfeeding among women in Dar es Salaam, Tanzania. Journal of Acquired Immune Deficiency Syndromes (1999). 31: 331-8. PMID 12439210 DOI: 10.1097/00126334-200211010-00010  0.535
2002 Loemba H, Brenner B, Parniak MA, Ma'ayan S, Spira B, Moisi D, Oliveira M, Detorio M, Essex M, Wainberg MA. Polymorphisms of cytotoxic T-lymphocyte (CTL) and T-helper epitopes within reverse transcriptase (RT) of HIV-1 subtype C from Ethiopia and Botswana following selection of antiretroviral drug resistance. Antiviral Research. 56: 129-42. PMID 12367719 DOI: 10.1016/S0166-3542(02)00100-6  0.499
2002 Fawzi WW, Msamanga GI, Hunter D, Renjifo B, Antelman G, Bang H, Manji K, Kapiga S, Mwakagile D, Essex M, Spiegelman D. Randomized trial of vitamin supplements in relation to transmission of HIV-1 through breastfeeding and early child mortality. Aids (London, England). 16: 1935-44. PMID 12351954 DOI: 10.1097/00002030-200209270-00011  0.491
2002 Novitsky V, Cao H, Rybak N, Gilbert P, McLane MF, Gaolekwe S, Peter T, Thior I, Ndung'u T, Marlink R, Lee TH, Essex M. Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C. Journal of Virology. 76: 10155-68. PMID 12239290 DOI: 10.1128/Jvi.76.20.10155-10168.2002  0.528
2002 Koulinska IN, Msamanga G, Mwakagile D, Essex M, Renjifo B. Common genetic arrangements among human immunodeficiency virus type 1 subtype A and D recombinant genomes vertically transmitted in Tanzania. Aids Research and Human Retroviruses. 18: 947-56. PMID 12230937 DOI: 10.1089/088922202760265614  0.431
2002 Loemba H, Brenner B, Parniak MA, Ma'ayan S, Spira B, Moisi D, Oliveira M, Detorio M, Essex M, Wainberg MA. Co-receptor usage and HIV-1 intra-clade C polymorphisms in the protease and reverse transcriptase genes of HIV-1 isolates from Ethiopia and Botswana. Antiviral Therapy. 7: 141-8. PMID 12212926  0.422
2002 Roof P, Ricci M, Genin P, Montano MA, Essex M, Wainberg MA, Gatignol A, Hiscott J. Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-kappaB and the Tat transactivator. Virology. 296: 77-83. PMID 12036319 DOI: 10.1006/Viro.2001.1397  0.54
2002 Novitsky V, Smith UR, Gilbert P, McLane MF, Chigwedere P, Williamson C, Ndung'u T, Klein I, Chang SY, Peter T, Thior I, Foley BT, Gaolekwe S, Rybak N, Gaseitsiwe S, ... ... Essex M, et al. Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design? Journal of Virology. 76: 5435-51. PMID 11991972 DOI: 10.1128/Jvi.76.11.5435-5451.2002  0.559
2002 Kapiga SH, Sam NE, Shao JF, Renjifo B, Masenga EJ, Kiwelu IE, Manongi R, Fawzi W, Essex M. HIV-1 epidemic among female bar and hotel workers in northern Tanzania: risk factors and opportunities for prevention. Journal of Acquired Immune Deficiency Syndromes (1999). 29: 409-17. PMID 11917247 DOI: 10.1097/00126334-200204010-00013  0.421
2002 Kapiga SH, Sam NE, Shao JF, Renjifo B, Masenga EJ, Kiwelu IE, Manongi R, Fawzi W, Essex M. HIV-1 epidemic among female bar and hotel workers in northern Tanzania: risk factors and opportunities for prevention. Journal of Acquired Immune Deficiency Syndromes (1999). 29: 409-17. PMID 11917247 DOI: 10.1097/00126334-200204010-00013  0.421
2001 Ndung'u T, Lu Y, Renjifo B, Touzjian N, Kushner N, Pena-Cruz V, Novitsky VA, Lee TH, Essex M. Infectious simian/human immunodeficiency virus with human immunodeficiency virus type 1 subtype C from an African isolate: rhesus macaque model. Journal of Virology. 75: 11417-25. PMID 11689623 DOI: 10.1128/Jvi.75.23.11417-11425.2001  0.57
2001 Novitsky V, Rybak N, McLane MF, Gilbert P, Chigwedere P, Klein I, Gaolekwe S, Chang SY, Peter T, Thior I, Ndung'u T, Vannberg F, Foley BT, Marlink R, Lee TH, ... Essex M, et al. Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design. Journal of Virology. 75: 9210-28. PMID 11533184 DOI: 10.1128/Jvi.75.19.9210-9228.2001  0.58
2001 Blackard JT, Renjifo B, Fawzi W, Hertzmark E, Msamanga G, Mwakagile D, Hunter D, Spiegelman D, Sharghi N, Kagoma C, Essex M. HIV-1 LTR subtype and perinatal transmission. Virology. 287: 261-5. PMID 11531404 DOI: 10.1006/Viro.2001.1059  0.712
2001 Gilbert PB, Novitsky VA, Montano MA, Essex M. An efficient test for comparing sequence diversity between two populations Journal of Computational Biology. 8: 123-139. PMID 11454301 DOI: 10.1089/106652701300312904  0.375
2001 Fawzi W, Msamanga G, Renjifo B, Spiegelman D, Urassa E, Hashemi L, Antelman G, Essex M, Hunter D. Predictors of intrauterine and intrapartum transmission of HIV-1 among Tanzanian women. Aids (London, England). 15: 1157-65. PMID 11416718 DOI: 10.1097/00002030-200106150-00011  0.546
2001 Ndung'u T, Renjifo B, Essex M. Construction and analysis of an infectious human immunodeficiency virus type 1 subtype C molecular clone Journal of Virology. 75: 4964-4972. PMID 11333875 DOI: 10.1128/Jvi.75.11.4964-4972.2001  0.565
2001 Koulinska IN, Ndung'u T, Mwakagile D, Msamanga G, Kagoma C, Fawzi W, Essex M, Renjifo B. A new human immunodeficiency virus type 1 circulating recombinant form from Tanzania. Aids Research and Human Retroviruses. 17: 423-31. PMID 11282011 DOI: 10.1089/088922201750102508  0.456
2001 Novitsky V, Flores-Villanueva PO, Chigwedere P, Gaolekwe S, Bussman H, Sebetso G, Marlink R, Yunis EJ, Essex M. Identification of most frequent HLA class I antigen specificities in Botswana: relevance for HIV vaccine design. Human Immunology. 62: 146-56. PMID 11182225 DOI: 10.1016/S0198-8859(00)00236-6  0.434
2001 Rivera-Morales LG, Novitsky VA, Trujillo JR, Lavalle-Montalvo C, Cano-Dominguez C, Ramos-Jimenez J, Jimenez-Rios E, Flores-Flores L, Lopez-Guillen P, Gilbert P, Vannberg F, Tamez-Guerra R, Rodriguez-Padilla C, Essex M. The molecular epidemiology of HIV type 1 of men in Mexico. Aids Research and Human Retroviruses. 17: 87-92. PMID 11177387 DOI: 10.1089/088922201750056825  0.512
2001 Browning CM, Smith MJ, Clark NM, Lane BR, Parada C, Montano M, KewalRamani VN, Littman DR, Essex M, Roeder RG, Markovitz DM. Human GLI-2 is a tat activation response element-independent Tat cofactor. Journal of Virology. 75: 2314-23. PMID 11160734 DOI: 10.1128/Jvi.75.5.2314-2323.2001  0.448
2001 Ndung'u T, Renjifo B, Novitsky VA, McLane MF, Gaolekwe S, Essex M. Molecular cloning and biological characterization of full-length HIV-1 subtype C from Botswana. Virology. 278: 390-9. PMID 11118362 DOI: 10.1006/Viro.2000.0583  0.578
2001 Wang WK, Lee CN, Dudek T, Chang SY, Zhao YJ, Essex M, Lee TH. Interaction between HIV type 1 glycoprotein 120 and CXCR4 coreceptor involves a highly conserved arginine residue in hypervariable region 3. Aids Research and Human Retroviruses. 16: 1821-9. PMID 11118068 DOI: 10.1089/08892220050195784  0.42
2001 Womack C, Roth W, Newman C, Rissing JP, Lovell R, Haburchak D, Essex M, Bond VC. Identification of non-B human immunodeficiency virus type 1 subtypes in rural Georgia Journal of Infectious Diseases. 183: 138-142. PMID 11106540 DOI: 10.1086/317649  0.494
2001 Lallemant M, Jourdain G, Le Coeur S, Kim S, Koetsawang S, Marie Comeau A, Phoolcharoen W, Essex M, McIntosh K, Vithayasai V. Trial of Shortened Zidovudine Regimens to Prevent Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1 Obstetric and Gynecologic Survey. 56: 138-139. DOI: 10.1097/00006254-200103000-00010  0.366
2000 Trujillo JR, Goletiani NV, Bosch I, Kendrick C, Rogers RA, Trujillo EB, Essex M, Brain JD. T-tropic sequence of the V3 loop is critical for HIV-1 infection of CXCR4-positive colonic HT-29 epithelial cells Journal of Acquired Immune Deficiency Syndromes. 25: 1-10. PMID 11064498 DOI: 10.1097/00042560-200009010-00001  0.527
2000 Brites C, Gilbert MJ, Pedral-Sampaio D, Bahia F, Pedroso C, Alcantara AP, Sasaki MD, Matos J, Renjifo B, Essex M, Whitmore JB, Agosti JM, Badaro R. A randomized, placebo-controlled trial of granulocyte-macrophage colony-stimulating factor and nucleoside analogue therapy in AIDS. The Journal of Infectious Diseases. 182: 1531-5. PMID 11023477 DOI: 10.1086/315901  0.412
2000 Lallemant M, Jourdain G, Le Coeur S, Kim S, Koetsawang S, Comeau AM, Phoolcharoen W, Essex M, McIntosh K, Vithayasai V. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. The New England Journal of Medicine. 343: 982-91. PMID 11018164 DOI: 10.1056/Nejm200010053431401  0.543
2000 Blackard JT, Renjifo B, Chaplin B, Msamanga G, Fawzi W, Essex M. Diversity of the HIV-1 long terminal repeat following mother-to-child transmission. Virology. 274: 402-11. PMID 10964782 DOI: 10.1006/Viro.2000.0466  0.67
2000 Chang SY, Vithayasai V, Vithayasai P, Essex M, Lee TH. Human immunodeficiency virus type 1 subtype E envelope recombinant peptides containing naturally immunogenic epitopes. The Journal of Infectious Diseases. 182: 442-50. PMID 10915074 DOI: 10.1086/315730  0.495
2000 Novitsky VA, Gaolekwe S, McLane MF, Ndung'u TP, Foley BT, Vannberg F, Marlink R, Essex M. HIV type 1 A/J recombinant with a pronounced pol gene mosaicism. Aids Research and Human Retroviruses. 16: 1015-20. PMID 10890363 DOI: 10.1089/08892220050058434  0.474
2000 Fawzi WW, Msamanga G, Hunter D, Urassa E, Renjifo B, Mwakagile D, Hertzmark E, Coley J, Garland M, Kapiga S, Antelman G, Essex M, Spiegelman D. Randomized trial of vitamin supplements in relation to vertical transmission of HIV-1 in Tanzania. Journal of Acquired Immune Deficiency Syndromes (1999). 23: 246-54. PMID 10839660 DOI: 10.1097/00126334-200003010-00006  0.55
2000 Choudhury S, Montano MA, Womack C, Blackard JT, Maniar JK, Saple DG, Tripathy S, Sahni S, Shah S, Babu GP, Essex M. Increased promoter diversity reveals a complex phylogeny of human immunodeficiency virus type 1 subtype C in India Journal of Human Virology. 3: 35-43. PMID 10774805  0.676
2000 Dieng Sarr A, Sankalé JL, Guèye-Ndiaye A, Essex M, Mboup S, Kanki PJ. Genetic analysis of HIV type 2 in monotypic and dual HIV infections Aids Research and Human Retroviruses. 16: 295-298. PMID 10710218 DOI: 10.1089/088922200309395  0.58
2000 Sarr AD, Sankalé JL, Hamel DJ, Travers KU, Guèye-Ndiaye A, Essex M, Mboup S, Kanki PJ. Interaction with human immunodeficiency virus (HIV) type 2 predicts HIV type 1 genotype. Virology. 268: 402-10. PMID 10704348 DOI: 10.1006/Viro.2000.0192  0.596
2000 Montano MA, Nixon CP, Ndung'u T, Bussmann H, Novitsky VA, Dickman D, Essex M. Elevated tumor necrosis factor-alpha activation of human immunodeficiency virus type 1 subtype C in Southern Africa is associated with an NF-kappaB enhancer gain-of-function. The Journal of Infectious Diseases. 181: 76-81. PMID 10608753 DOI: 10.1086/315185  0.464
2000 Chang SY, Apichartpiyakul C, Kuiken CL, Essex M, Lee TH. Sequence features downstream of the primer-binding site of HIV type 1 subtype E shared by subtype G and a subset of subtype A. Aids Research and Human Retroviruses. 15: 1703-6. PMID 10606093 DOI: 10.1089/088922299309748  0.478
2000 Heyndrickx L, Janssens W, Zekeng L, Musonda R, Anagonou S, Van der Auwera G, Coppens S, Vereecken K, De Witte K, Van Rampelbergh R, Kahindo M, Morison L, McCutchan FE, Carr JK, Albert J, ... Essex M, et al. Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay. Study Group on Heterogeneity of HIV Epidemics in African Cities. Journal of Virology. 74: 363-70. PMID 10590125 DOI: 10.1128/Jvi.74.1.363-370.2000  0.459
2000 Fawzi WW, Msamanga G, Hunter D, Urassa E, Renjifo B, Mwakagile D, Hertzmark E, Coley J, Garland M, Kapiga S, Antelman G, Essex M, Spiegelman D. Randomized Trial of Vitamin Supplements in Relation to Vertical Transmission of HIV-1 in Tanzania Journal of Acquired Immune Deficiency Syndromes. 23: 246-254. DOI: 10.1097/00042560-200003010-00006  0.339
1999 Essex M. Human immunodeficiency viruses in the developing world Advances in Virus Research. 53: 71-88. PMID 10582095 DOI: 10.1016/S0065-3527(08)60343-7  0.592
1999 Chang SY, Sutthent R, Auewarakul P, Apichartpiyakul C, Essex M, Lee TH. Differential stability of the mRNA secondary structures in the frameshift site of various HIV type 1 viruses. Aids Research and Human Retroviruses. 15: 1591-6. PMID 10580411 DOI: 10.1089/088922299309892  0.506
1999 Renjifo B, Gilbert P, Chaplin B, Vannberg F, Mwakagile D, Msamanga G, Hunter D, Fawzi W, Essex M. Emerging recombinant human immunodeficiency viruses: uneven representation of the envelope V3 region. Aids (London, England). 13: 1613-21. PMID 10509561 DOI: 10.1097/00002030-199909100-00003  0.471
1999 Philippon V, Matsuda Z, Essex M. Transactivation is a conserved function among primate lentivirus Vpr proteins but is not shared by Vpx Journal of Human Virology. 2: 167-174. PMID 10413368  0.49
1999 Renjifo B, Blackard JT, Klaskala W, Chaplin BR, Shah P, McLane MF, Barin F, Esparza J, Zelaya JE, Osmanov S, Soto R, Fernandez JA, Baum MK, Essex ME. HIV-1 subtype B in Honduras. Virus Research. 60: 191-7. PMID 10392727 DOI: 10.1016/S0168-1702(99)00014-3  0.689
1999 Wang WK, Dudek T, Essex M, Lee TH. Hypervariable region 3 residues of HIV type 1 gp120 involved in CCR5 coreceptor utilization: therapeutic and prophylactic implications. Proceedings of the National Academy of Sciences of the United States of America. 96: 4558-62. PMID 10200301 DOI: 10.1073/Pnas.96.8.4558  0.509
1999 Novitsky VA, Montano MA, McLane MF, Renjifo B, Vannberg F, Foley BT, Ndung'u TP, Rahman M, Makhema MJ, Marlink R, Essex M. Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from Botswana. Journal of Virology. 73: 4427-32. PMID 10196340 DOI: 10.1128/Jvi.73.5.4427-4432.1999  0.567
1999 Roth WW, Womack C, Newman C, Essex M, Bond VC. Phylogenetic examination of HIV type 1 glycoprotein 120-V3 sequences in patients from rural Georgia Aids Research and Human Retroviruses. 15: 399-403. PMID 10082125 DOI: 10.1089/088922299311385  0.55
1999 Blackard JT, Renjifo BR, Mwakagile D, Montano MA, Fawzi WW, Essex M. Transmission of human immunodeficiency type 1 viruses with intersubtype recombinant long terminal repeat sequences. Virology. 254: 220-5. PMID 9986788 DOI: 10.1006/Viro.1998.9504  0.705
1998 Essex M. State of the HIV pandemic Journal of Human Virology. 1: 427-429. PMID 10195263  0.433
1998 Popper SJ, Sankalé JL, Thior I, Siby T, Marlink RG, Mboup S, Essex M, Kanki PJ. Antibodies to the HIV type 2 core protein p26 and Vpx: Association with disease progression Aids Research and Human Retroviruses. 14: 1157-1162. PMID 9737587 DOI: 10.1089/Aid.1998.14.1157  0.478
1998 Montano MA, Nixon CP, Essex M. Dysregulation through the NF-κB enhancer and TATA box of the human immunodeficiency virus type 1 subtype E promoter Journal of Virology. 72: 8446-8452. PMID 9733900 DOI: 10.1128/Jvi.72.10.8446-8452.1998  0.557
1998 Novitsky VA, Montano MA, Essex M. Molecular epidemiology of an HIV-1 subtype A subcluster among injection drug users in the Southern Ukraine Aids Research and Human Retroviruses. 14: 1079-1085. PMID 9718124 DOI: 10.1089/Aid.1998.14.1079  0.569
1998 Renjifo B, Chaplin B, Mwakagile D, Shah P, Vannberg F, Msamanga G, Hunter D, Fawzi W, Essex M. Epidemic expansion of HIV type 1 subtype C and recombinant genotypes in Tanzania. Aids Research and Human Retroviruses. 14: 635-8. PMID 9591718 DOI: 10.1089/Aid.1998.14.635  0.542
1998 Wang WK, Dudek T, Zhao YJ, Brumblay HG, Essex M, Lee TH. CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120. Proceedings of the National Academy of Sciences of the United States of America. 95: 5740-5. PMID 9576954 DOI: 10.1073/Pnas.95.10.5740  0.542
1998 Lallemant M, McIntosh K, Le Coeur S, Vithayasai V, Lek T, Hammer S, Prescott N, Essex M. Letter to the editor of the NEJM Reproductive Health Matters. 6: 139-140. DOI: 10.1016/S0968-8080(98)90100-8  0.331
1997 Thior I, Diouf G, Diaw IK, Sarr AD, Hsieh CC, Ndoye I, Mboup S, Chen L, Essex M, Marlink R, Kanki P. Sexually transmitted diseases and risk of HIV infection in men attending a sexually transmitted diseases clinic in Dakar, Senegal African Journal of Reproductive Health. 1: 26-35. PMID 10214412 DOI: 10.2307/3583374  0.498
1997 Essex M. The human immunodeficiency virus (HIV) as a newly evolving pathogen Southeast Asian Journal of Tropical Medicine and Public Health. 28: 127-130. PMID 9561648  0.484
1997 Montano MA, Novitsky VA, Blackard JT, Cho NL, Katzenstein DA, Essex M. Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes. Journal of Virology. 71: 8657-65. PMID 9343223 DOI: 10.1128/Jvi.71.11.8657-8665.1997  0.744
1997 Soto-Ramirez LE, Garcia-Vallejo F, Renjifo B, Vergara A, Borrero I, Marlink R, Essex M. Human T-lymphotropic virus type I (HTLV-I)-specific antibodies and cell-free RNA in crevicular fluid-rich saliva from patients with tropical spastic paraparesis/HTLV-I-associated myelopathy. Viral Immunology. 8: 141-50. PMID 8833267 DOI: 10.1089/Vim.1995.8.141  0.332
1996 Soto-Ramirez LE, Tripathy S, Renjifo B, Essex M. HIV-1 pol sequences from India fit distinct subtype pattern Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 13: 299-307. PMID 8948366 DOI: 10.1097/00042560-199612010-00001  0.51
1996 Essex M. Retroviral vaccines: Challenges for the developing world Aids Research and Human Retroviruses. 12: 361-363. PMID 8882311 DOI: 10.1089/Aid.1996.12.361  0.586
1996 Tripathy S, Renjifo B, Wang WK, McLane MF, Bollinger R, Rodrigues J, Osterman J, Tripathy S, Essex M. Envelope glycoprotein 120 sequences of primary HIV type 1 isolates from Pune and New Delhi, India. Aids Research and Human Retroviruses. 12: 1199-202. PMID 8844026 DOI: 10.1089/Aid.1996.12.1199  0.505
1996 Wang WK, Mayer KH, Essex M, Lee TH. Sequential change of cysteine residues in hypervariable region 1 of glycoprotein 120 in primary HIV type 1 isolates of subtype B Aids Research and Human Retroviruses. 12: 1195-1197. PMID 8844025 DOI: 10.1089/Aid.1996.12.1195  0.501
1996 Wang WK, Essex M, McLane MF, Mayer KH, Hsieh CC, Brumblay HG, Seage G, Lee TH. Pattern of gp120 sequence divergence linked to a lack of clinical progression in human immunodeficiency virus type 1 infection. Proceedings of the National Academy of Sciences of the United States of America. 93: 6693-7. PMID 8692880 DOI: 10.1073/Pnas.93.13.6693  0.48
1996 Soto-Ramirez LE, Renjifo B, McLane MF, Marlink R, O'Hara C, Sutthent R, Wasi C, Vithayasai P, Vithayasai V, Apichartpiyakul C, Auewarakul P, Cruz VP, Chui DS, Osathanondh R, Mayer K, ... ... Essex M, et al. HIV-1 Langerhans' Cell Tropism Associated with Heterosexual Transmission of HIV Science. 271: 1291-1293. PMID 8638113 DOI: 10.1126/Science.271.5253.1291  0.585
1996 Trujillo JR, Navia BA, Worth J, Lucey DR, McLane MF, Lee TH, Essex M. High levels of anti-HIV-1 envelope antibodies in cerebrospinal fluid as compared to serum from patients with AIDS dementia complex. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association. 12: 19-25. PMID 8624756 DOI: 10.1097/00042560-199605010-00003  0.318
1996 Trujllo JR, Wang WK, Lee TH, Essex M. Identification of the envelope V3 loop as a determinant of a CD4-negative neuronal cell tropism for HIV-1 Virology. 217: 613-617. PMID 8610455 DOI: 10.1006/Viro.1996.0158  0.498
1996 Wang WK, Essex M, Lee TH. Single amino acid substitution in constant region 1 or 4 of gp120 causes the phenotype of a human immunodeficiency virus type 1 variant with mutations in hypervariable regions 1 and 2 to revert Journal of Virology. 70: 607-611. PMID 8523579 DOI: 10.1128/Jvi.70.1.607-611.1996  0.36
1995 Essex M. The hunt for the AIDS vaccine Aids Asia : Voice of the Asian Solidarity Against Aids. 2: 10-13. PMID 12319586  0.348
1995 Wang WK, Essex M, Lee TH. The highly conserved aspartic acid residue between hypervariable regions 1 and 2 of human immunodeficiency virus type 1 gp120 is important for early stages of virus replication Journal of Virology. 69: 538-542. PMID 7983752 DOI: 10.1128/Jvi.69.1.538-542.1995  0.5
1995 Renjifo B, Borrero I, Essex M. Tax mutation associated with tropical spastic paraparesis/human T-cell leukemia virus type I-associated myelopathy Journal of Virology. 69: 2611-2616. PMID 7884912 DOI: 10.1128/Jvi.69.4.2611-2616.1995  0.344
1995 Lallemant M, Le Coeur S, Samba L, Cheynier D, M'Pelé P, Nzingoula S, Essex M. Mother-to-child transmission of HIV-1 in Congo, central Africa. Congolese Research Group on Mother-to-Child Transmission of HIV. Aids (London, England). 8: 1451-6. PMID 7818816 DOI: 10.1097/00002030-199410000-00012  0.499
1995 Wang WK, Essex M, Lee TH. Uncommon gp120 cysteine residues found in primary HIV-1 isolates Aids Research and Human Retroviruses. 11: 185-188. PMID 7734192 DOI: 10.1089/Aid.1995.11.185  0.508
1994 Essex M. Simian immunodeficiency virus in people New England Journal of Medicine. 330: 209-210. PMID 8264747 DOI: 10.1056/Nejm199401203300313  0.572
1994 Kashala O, Mubikayi L, Kayembe K, Mukeba P, Essex M. Hepatitis B virus activation among central Africans infected with human immunodeficiency virus (HIV) type 1: pre-s2 antigen is predominantly expressed in HIV infection. The Journal of Infectious Diseases. 169: 628-32. PMID 8158039 DOI: 10.1093/Infdis/169.3.628  0.606
1994 Yu QC, Matsuda Z, Yu X, Ito S, Essex M, Lee TH. An electron-lucent region within the virion distinguishes HIV-1 from HIV-2 and simian immunodeficiency virus. Aids Research and Human Retroviruses. 10: 757-61. PMID 8074937 DOI: 10.1089/Aid.1994.10.757  0.59
1994 Yu X, Mclane MF, Ratner L, O'Brien W, Collman R, Essex M, Lee TH. Killing of primary CD4+ T cells by non-syncytium-inducing macrophage-tropic human immunodeficiency virus type 1 Proceedings of the National Academy of Sciences of the United States of America. 91: 10237-10241. PMID 7937869 DOI: 10.1073/Pnas.91.21.10237  0.519
1994 Marlink R, Kanki P, Thior I, Travers K, Eisen G, Siby T, Traore I, Hsieh CC, Dia MC, Gueye EH, Hellinger J, Guèye-Ndiaye A, Sankalé JL, Ndoye I, Mboup S, ... Essex M, et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1 Science. 265: 1587-1590. PMID 7915856 DOI: 10.1126/Science.7915856  0.591
1994 Lallemant M, Le Coeur S, Tarantola D, Mann J, Essex M. Antiretroviral prevention of HIV perinatal transmission. Lancet (London, England). 343: 1429-30. PMID 7910905 DOI: 10.1016/S0140-6736(94)92552-6  0.557
1994 Lallemant M, Baillou A, Lallemant-Le Coeur S, Nzingoula S, Mampaka M, M'Pelé P, Barin F, Essex M. Maternal antibody response at delivery and perinatal transmission of human immunodeficiency virus type 1 in African women. Lancet (London, England). 343: 1001-5. PMID 7909048 DOI: 10.1016/S0140-6736(94)90126-0  0.349
1994 Kashala O, Marlink R, Ilunga M, Diese M, Gormus B, Xu K, Mukeba P, Kasongo K, Essex M. Infection with human immunodeficiency virus type 1 (HIV-1) and human T cell lymphotropic viruses among leprosy patients and contacts: correlation between HIV-1 cross-reactivity and antibodies to lipoarabinomannan. The Journal of Infectious Diseases. 169: 296-304. PMID 7906291 DOI: 10.1093/Infdis/169.2.296  0.566
1994 Carini C, McLane MF, Mayer KH, Essex M. Dysregulation of interleukin-7 receptor may generate loss of cytotoxic T cell response in human immunodeficiency virus type 1 infection European Journal of Immunology. 24: 2927-2934. PMID 7805718 DOI: 10.1002/Eji.1830241202  0.363
1994 Lee CN, Robinson J, Cheng YL, Essex M, Lee TH. Influence of deletions in N or C terminus of HIV-1 glycoprotein 120 on binding of infectivity-enhancing antibody Aids Research and Human Retroviruses. 10: 1065-1069. PMID 7530023 DOI: 10.1089/Aid.1994.10.1065  0.412
1993 Roingeard P, Diouf A, Sankale JL, Boye C, Mboup S, Diadhiou F, Essex M. Perinatal transmission of hepatitis B virus in Senegal, West Africa Viral Immunology. 6: 65-73. PMID 8476509 DOI: 10.1089/Vim.1993.6.65  0.302
1993 Kashala O, Kayembe K, Kanki P, Mukeba P, Diese M, Kalengayi M, Izzia KW, Essex M. Humoral aspects of anti-HIV immune responses in Zairians with AIDS: Lower antigenemia does not correlate with immune complex levels Aids Research and Human Retroviruses. 9: 251-258. PMID 8471316 DOI: 10.1089/Aid.1993.9.251  0.507
1993 Yu X, Yuan X, McLane MF, Lee TH, Essex M. Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions. Journal of Virology. 67: 213-21. PMID 8416370 DOI: 10.1128/Jvi.67.1.213-221.1993  0.38
1993 Yuan X, Yu X, Lee TH, Essex M. Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor Journal of Virology. 67: 6387-6394. PMID 8411340 DOI: 10.1128/Jvi.67.11.6387-6394.1993  0.314
1993 Trujillo JR, McLane MF, Lee TH, Essex M. Molecular mimicry between the human immunodeficiency virus type 1 gp120 V3 loop and human brain proteins Journal of Virology. 67: 7711-7715. PMID 8230494 DOI: 10.1128/Jvi.67.12.7711-7715.1993  0.334
1993 Matsuda Z, Yu X, Yu QC, Lee TH, Essex M. A virion-specific inhibitory molecule with therapeutic potential for human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences of the United States of America. 90: 3544-8. PMID 7682710 DOI: 10.1073/Pnas.90.8.3544  0.568
1992 Lee WR, Yu XF, Syu WJ, Essex M, Lee TH. Mutational analysis of conserved N-linked glycosylation sites of human immunodeficiency virus type 1 gp41. Journal of Virology. 66: 1799-803. PMID 1738209 DOI: 10.1128/Jvi.66.3.1799-1803.1992  0.355
1992 Yu X, Yuan X, Matsuda Z, Lee TH, Essex M. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. Journal of Virology. 66: 4966-71. PMID 1629961 DOI: 10.1128/Jvi.66.8.4966-4971.1992  0.348
1992 Lee WR, Syu WJ, Du B, Matsuda M, Tan S, Wolf A, Essex M, Lee TH. Nonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences of the United States of America. 89: 2213-7. PMID 1549584 DOI: 10.1073/Pnas.89.6.2213  0.338
1992 Xiaofang YU, Qian-Chun YU, Lee TH, Essex M. The C terminus of human immunodeficiency virus type 1 matrix protein is involved in early steps of the virus life cycle Journal of Virology. 66: 5667-5670. PMID 1501299 DOI: 10.1128/Jvi.66.9.5667-5670.1992  0.335
1992 Kovacsovics-Bankowski M, Carini C, Kashala O, Essex M. Isotypic distribution of HIV-1-specific antibodies in individuals from Central Africa Viral Immunology. 5: 243-248. PMID 1472277 DOI: 10.1089/Vim.1992.5.243  0.493
1991 Yuan X, Matsuda Z, Matsuda M, Essex M, Lee TH. Human immunodeficiency virus vpr gene encodes a virion-associated protein. Aids Research and Human Retroviruses. 6: 1265-71. PMID 2150318 DOI: 10.1089/Aid.1990.6.1265  0.51
1991 Chen YM, Okayama A, Lee TH, Tachibana N, Mueller N, Essex M. Sexual transmission of human T-cell leukemia virus type I associated with the presence of anti-Tax antibody. Proceedings of the National Academy of Sciences of the United States of America. 88: 1182-6. PMID 1996321 DOI: 10.1073/Pnas.88.4.1182  0.316
1991 Baillou A, Janvier B, Mayer R, Kanki P, M'Boup S, Denis F, Goudeau A, Essex M, Barin F. Site-directed serology using synthetic oligopeptides representing the C-terminus of the external glycoproteins of HIV-1, HIV-2, or SIV(mac) may distinguish subtypes among primate lentiviruses Aids Research and Human Retroviruses. 7: 767-771. PMID 1720632 DOI: 10.1089/Aid.1991.7.767  0.569
1991 Syu WJ, Lee WR, Du B, Yu QC, Essex M, Lee TH. Role of conserved gp41 cysteine residues in the processing of human immunodeficiency virus envelope precursor and viral infectivity. Journal of Virology. 65: 6349-52. PMID 1717722 DOI: 10.1128/Jvi.65.11.6349-6352.1991  0.355
1991 Yu XF, Yu QC, Essex M, Lee TH. The vpx gene of simian immunodeficiency virus facilitates efficient viral replication in fresh lymphocytes and macrophages Journal of Virology. 65: 5088-5091. PMID 1714525 DOI: 10.1128/Jvi.65.9.5088-5091.1991  0.381
1991 Huang ML, Essex M, Lee TH. Localization of immunogenic domains in the human immunodeficiency virus type 2 envelope Journal of Virology. 65: 5073-5079. PMID 1714524  0.486
1990 Roingeard P, Lu SL, Sureau C, Freschlin M, Arbeille B, Essex M, Romet-Lemonne JL. Immunocytochemical and electron microscopic study of hepatitis B virus antigen and complete particle production in hepatitis B virus DNA transfected HepG2 cells. Hepatology (Baltimore, Md.). 11: 277-85. PMID 2407629 DOI: 10.1002/Hep.1840110219  0.339
1990 Hellinger J, Marlink R, Kaptue L, Zekeng L, Essex M. Are tuberculosis patients a 'sentinel' population for HIV epidemic in Africa? Transactions of the Royal Society of Tropical Medicine and Hygiene. 84: 292. PMID 2389324 DOI: 10.1016/0035-9203(90)90291-L  0.379
1990 Syu WJ, Huang JH, Essex M, Lee TH. The N-terminal region of the human immunodeficiency virus envelope glycoprotein gp120 contains potential binding sites for CD4 Proceedings of the National Academy of Sciences of the United States of America. 87: 3695-3699. PMID 2339113 DOI: 10.1073/Pnas.87.10.3695  0.435
1990 Essex M, Kanki PJ, Marlink R, Chou MJ, Lee TH. Antigenic characterization of the human immunodeficiency viruses Journal of the American Academy of Dermatology. 22: 1206-1210. PMID 2193947 DOI: 10.1016/0190-9622(90)70164-D  0.563
1989 Ayanian JZ, Maguire JH, Marlink RG, Essex M, Kanki PJ. HIV-2 infection in the United States New England Journal of Medicine. 320: 1422-1423. PMID 2716792 DOI: 10.1056/Nejm198905253202119  0.512
1989 Essex M, Matsuda Z, Yu X, Kanki P, Lee T. Immunology of HIV Vaccine. 7: 188. DOI: 10.1016/0264-410X(89)90133-3  0.562
1988 Essex M, Kanki PJ. The origins of the AIDS virus Scientific American. 259: 64-71. PMID 2907683 DOI: 10.1038/Scientificamerican1088-64  0.558
1988 Matsuda Z, Chou MJ, Matsuda M, Huang JH, Chen YM, Redfield R, Mayer K, Essex M, Lee TH. Human immunodeficiency virus type 1 has an additional coding sequence in the central region of the genome. Proceedings of the National Academy of Sciences of the United States of America. 85: 6968-72. PMID 2842797 DOI: 10.1073/pnas.85.18.6968  0.461
1988 Yu XF, Ito S, Essex M, Lee TH. A naturally immunogenic virion-associated protein specific for HIV-2 and SIV Nature. 335: 262-265. PMID 2842694 DOI: 10.1038/335262A0  0.577
1987 Azocar J, Martinez C, McLane MF, Allan J, Essex M. Lack of endemic HIV infection in Venezuela. Aids Research and Human Retroviruses. 3: 107-8. PMID 3650099 DOI: 10.1089/Aid.1987.3.107  0.514
1987 Marlink R, Anderson K, Essex M, Groopman J. Transfusion-acquired HIV infection among immunocompromised hosts Hamatologie Und Bluttransfusion. 31: 410-413. PMID 3481757 DOI: 10.1007/978-3-642-72624-8_88  0.539
1987 Kanki PJ, Hopper JR, Essex M. The origins of HIV-1 and HTLV-4/HIV-2 Annals of the New York Academy of Sciences. 511: 370-375. PMID 2894192 DOI: 10.1111/j.1749-6632.1987.tb36265.x  0.507
1987 Robey WG, Nara PL, Poore CM, Popovic M, McLane MF, Barin F, Essex M, Fischinger PJ. Rapid assessment of relationships among HIV isolates by oligopeptide analyses of external envelope glycoproteins. Aids Research and Human Retroviruses. 3: 401-8. PMID 2833916 DOI: 10.1089/Aid.1987.3.401  0.429
1987 Barin F, Denis F, Baillou A, Leonard G, Mounier M, M'Boup S, Gershy-Damet G, Sangare A, Kanki P, Essex M. A STLV-III related human retrovirus, HTLV-IV: analysis of cross-reactivity with the human immunodeficiency virus (HIV). Journal of Virological Methods. 17: 55-61. PMID 2444614 DOI: 10.1016/0166-0934(87)90068-1  0.474
1987 BIBERFELD G, BROWN F, ESPARZA J, ESSEX M, GALLO RC, MONTAGNIER L, NAJERA R, RISSER R, SCHILD G. WHO Working Group on Characterization of HIV-Related Retroviruses: Criteria for Characterization and Proposal for a Nomenclature System Aids Research and Human Retroviruses. 3: 241-243. DOI: 10.1089/Aid.1987.3.241  0.393
1986 Marlink RG, Allan JS, Mclane MF, Essex M, Anderson KC, Groopman JE. Low sensitivity of ELISA testing in early HIV infection. The New England Journal of Medicine. 315: 1549-1549. PMID 3466032 DOI: 10.1056/Nejm198612113152413  0.521
1986 Wernicke D, Trainin Z, Ungar-Waron H, Essex M. Humoral immune response of asymptomatic cats naturally infected with feline leukemia virus Journal of Virology. 60: 669-673. PMID 3022000 DOI: 10.1128/Jvi.60.2.669-673.1986  0.321
1986 Sureau C, Romet-Lemonne JL, Mullins JI, Essex M. Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA Cell. 47: 37-47. PMID 3019565 DOI: 10.1016/0092-8674(86)90364-8  0.302
1986 Marlink R, Allan J, Essex M. UNUSUAL SEROLOGICAL PROFILES IN AIDS The Lancet. 327: 1389. PMID 2872505 DOI: 10.1016/S0140-6736(86)91704-6  0.342
1985 Essex M, Allan J, Kanki P, McLane MF, Malone G, Kitchen L, Lee TH. Antigens of human T-lymphotropic virus type III/lymphadenopathy-associated virus Annals of Internal Medicine. 103: 700-703. PMID 2996402 DOI: 10.1016/S0022-5347(17)44960-3  0.348
1985 Kreiss JK, Kitchen LW, Prince HE, Kasper CK, Essex M. Antibody to human T-lymphotropic virus type III in wives of hemophiliacs. Evidence for heterosexual transmission. Annals of Internal Medicine. 102: 623-6. PMID 2984972 DOI: 10.7326/0003-4819-102-5-623  0.338
1985 Goh WC, Sodroski J, Rosen C, Essex M, Haseltine WA. Subcellular localization of the product of the long open reading frame of human T-cell leukemia virus type I Science. 227: 1227-1228. PMID 2983419 DOI: 10.1126/Science.2983419  0.335
1985 Dienstag JL, Werner BG, McLane MF, Snydman DR, Grady GF, Craven DE, Crumpacker CS, Polk BF, Platt R, Allan J, Essex M. Absence of antibodies to HTLV-III in health workers after hepatitis B vaccination. Jama. 254: 1064-1066. DOI: 10.1001/Jama.1985.03360080076033  0.347
1984 Mathez D, Leibowitch J, Catalan P, Essex M, Zaguri D. HTLV and AIDS in France Lancet. 1: 799. PMID 6143123 DOI: 10.1016/S0140-6736(84)91319-9  0.312
1982 Essex M. Adult T-cell leukemia-lymphoma: Role of a human retrovirus Journal of the National Cancer Institute. 69: 981-985. DOI: 10.1093/Jnci/69.4.981  0.355
1978 Sherr CJ, Todaro GJ, Sliski A, Essex M. Characterization of a feline sarcoma virus-coded antigen (FOCMA-S) by radioimmunoassay. Proceedings of the National Academy of Sciences of the United States of America. 75: 4489-93. PMID 212755 DOI: 10.1073/Pnas.75.9.4489  0.317
1978 Sherr CJ, Sen A, Todaro GJ, Sliski A, Essex M. Pseudotypes of feline sarcoma virus contain an 85,000-dalton protein with feline oncornavirus-associated cell membrane antigen (FOCMA) activity. Proceedings of the National Academy of Sciences of the United States of America. 75: 1505-9. PMID 206902 DOI: 10.1073/Pnas.75.3.1505  0.311
1977 Sliski AH, Essex M, Meyer C, Todaro G. Feline Oncornavirus-associated cell membrane antigen: Expression in transformed nonproducer mink cells Science. 196: 1336-1339. PMID 194310 DOI: 10.1126/Science.194310  0.303
Low-probability matches (unlikely to be authored by this person)
2018 Zash R, Rough K, Jacobson DL, Diseko M, Mayondi G, Mmalane M, Essex M, Petlo C, Lockman S, Makhema J, Shapiro RL. Effect of Gestational Age at Tenofovir-Emtricitabine-Efavirenz Initiation on Adverse Birth Outcomes in Botswana. Journal of the Pediatric Infectious Diseases Society. PMID 29688554 DOI: 10.1093/Jpids/Piy006  0.3
2016 Zash RM, Shapiro RL, Leidner J, Wester C, McAdam AJ, Hodinka RL, Thior I, Moffat C, Makhema J, McIntosh K, Essex M, Lockman S. The aetiology of diarrhoea, pneumonia and respiratory colonization of HIV-exposed infants randomized to breast- or formula-feeding. Paediatrics and International Child Health. 1-9. PMID 27077612 DOI: 10.1080/20469047.2015.1109270  0.298
1991 Chen YMA, Essex M. Identification of a recombinant HTLV-II envelope protein for serological detection of HTLV-II carriers Aids Research and Human Retroviruses. 7: 453-457. PMID 1873080 DOI: 10.1089/Aid.1991.7.453  0.298
1987 Archibald D, Essex M, McLane MF, Sauk J, Tachibana N, Mueller N. Antibodies to HTLV-1 in saliva of seropositive individuals from Japan. Viral Immunology. 1: 241-6. PMID 3509678 DOI: 10.1089/Vim.1987.1.241  0.296
1994 Carini C, Essex M. Interleukin 2-independent interleukin 7 activity enhances cytotoxic immune response of HIV-1-infected individuals Aids Research and Human Retroviruses. 10: 121-130. PMID 7515256 DOI: 10.1089/Aid.1994.10.121  0.295
1991 Okayama A, Chen YM, Tachibana N, Shioiri S, Lee TH, Tsuda K, Essex M. High incidence of antibodies to HTLV-I tax in blood relatives of adult T cell leukemia patients. The Journal of Infectious Diseases. 163: 47-52. PMID 1984476 DOI: 10.1093/Infdis/163.1.47  0.295
2008 Bae WH, Wester C, Smeaton LM, Shapiro RL, Lockman S, Onyait K, Thior I, Essex M. Hematologic and hepatic toxicities associated with antenatal and postnatal exposure to maternal highly active antiretroviral therapy among infants. Aids (London, England). 22: 1633-40. PMID 18670224 DOI: 10.1097/Qad.0B013E328307A029  0.295
1988 Gessain A, Caudie C, Gout O, Vernant JC, Maurs L, Giordano C, Malone G, Tournier-Lasserve E, Essex M, de-Thé G. Intrathecal synthesis of antibodies to human T lymphotropic virus type I and the presence of IgG oligoclonal bands in the cerebrospinal fluid of patients with endemic tropical spastic paraparesis. The Journal of Infectious Diseases. 157: 1226-34. PMID 2897399 DOI: 10.1093/Infdis/157.6.1226  0.294
1995 Chou KS, Okayama A, Tachibana N, Lee TH, Essex M. Nucleotide sequence analysis of a full-length human T-cell leukemia virus type I from adult T-cell leukemia cells: a prematurely terminated PX open reading frame II. International Journal of Cancer. 60: 701-6. PMID 7860146 DOI: 10.1002/Ijc.2910600522  0.291
1995 Renjifo B, Osterman J, Borrero I, Essex M. Nucleotide sequences of human T-lymphotropic virus type I (HTLV-I) from a family cluster with tropical spastic paraparesis/ HTLV-I-associated myelopathy Research in Virology. 146: 93-99. PMID 7638441 DOI: 10.1016/0923-2516(96)81078-8  0.29
1983 Trainin Z, Wernicke D, Ungar Waron H, Essex M. Suppression of the humoral antibody response in natural retrovirus infections Science. 220: 858-859. PMID 6302837 DOI: 10.1126/Science.6302837  0.29
1990 Roingeard P, Romet-Lemonne J, Leturcq D, Goudeau A, Essex M. Hepatitis B virus core antigen (HBc Ag) accumulation in an HBV nonproducer clone of HepG2-transfected cells is associated with cytopathic effect. Virology. 179: 113-120. PMID 2171201 DOI: 10.1016/0042-6822(90)90280-5  0.288
1995 Lee CN, Robinson J, Mazzara G, Cheng YL, Essex M, Lee TH. Contribution of hypervariable domains to the conformation of a broadly neutralizing glycoprotein 120 epitope. Aids Research and Human Retroviruses. 11: 777-81. PMID 7546903 DOI: 10.1089/Aid.1995.11.777  0.288
1995 Essex M. Strategies of research for a vaccine against AIDS History and Philosophy of the Life Sciences. 17: 141-149. PMID 8552747  0.285
1996 Chou KS, Okayama A, Su IJ, Lee TH, Essex M. Preferred nucleotide sequence at the integration target site of human T-cell leukemia virus type I from patients with adult T-cell leukemia. International Journal of Cancer. 65: 20-4. PMID 8543390 DOI: 10.1002/(Sici)1097-0215(19960103)65:1<20::Aid-Ijc4>3.0.Co;2-3  0.284
1988 Chou MJ, Lee TH, Hatzakis A, Mandalaki T, McLane MF, Essex M. Antibody responses in early human immunodeficiency virus type 1 infection in hemophiliacs Journal of Infectious Diseases. 157: 805-811. PMID 3346572 DOI: 10.1093/Infdis/157.4.805  0.281
1998 Shioiri S, Stuver SO, Okayama A, Murai K, Shima T, Tachibana N, Tsubouchi H, Essex M, Mueller N. Intrafamilial transmission of HTLV-I and its association with anti-Tax antibody in an endemic population in Japan. International Journal of Cancer. Journal International Du Cancer. 75: 15-8. PMID 9426684 DOI: 10.1002/(Sici)1097-0215(19980105)75:1<15::Aid-Ijc3>3.0.Co;2-4  0.279
1977 Stephenson JR, Khan AS, Sliski AH, Essex M. Feline oncornavirus-associated cell membrane antigen: evidence for an immunologically crossreactive feline sarcoma virus-coded protein. Proceedings of the National Academy of Sciences of the United States of America. 74: 5608-12. PMID 202959 DOI: 10.1073/Pnas.74.12.5608  0.279
2012 Rossenkhan R, Novitsky V, Sebunya TK, Leidner J, Hagan JE, Moyo S, Smeaton L, Lockman S, Musonda R, Ndung'u T, Gaseitsiwe S, Thior I, Mmalane M, Makhema J, Essex M, et al. Infant feeding practices were not associated with breast milk HIV-1 RNA levels in a randomized clinical trial in Botswana. Aids and Behavior. 16: 1260-4. PMID 21901486 DOI: 10.1007/s10461-011-0035-7  0.279
2010 Wester CW, Thomas AM, Bussmann H, Moyo S, Makhema JM, Gaolathe T, Novitsky V, Essex M, deGruttola V, Marlink RG. Non-nucleoside reverse transcriptase inhibitor outcomes among combination antiretroviral therapy-treated adults in Botswana. Aids (London, England). 24: S27-36. PMID 20023437 DOI: 10.1097/01.Aids.0000366080.91192.55  0.278
1995 Essex M, Matsuda Z, Yu X, Lee TH. Gene therapy against retroviral diseases Leukemia. 9. PMID 7475320  0.277
2003 Kushner N, Zhang D, Touzjian N, Essex M, Lieberman J, Lu Y. A fragment of anthrax lethal factor delivers proteins to the cytosol without requiring protective antigen. Proceedings of the National Academy of Sciences of the United States of America. 100: 6652-7. PMID 12740437 DOI: 10.1073/Pnas.1131930100  0.275
1993 Shioiri S, Tachibana N, Okayama A, Ishihara S, Tsuda K, Essex M, Stuver SO, Mueller N. Analysis of anti-Tax antibody of HTLV-I carriers in an endemic area in Japan. International Journal of Cancer. Journal International Du Cancer. 53: 1-4. PMID 8416192 DOI: 10.1002/Ijc.2910530102  0.275
1984 Kreiss JK, Lawrence DN, Kasper CK, Goldstein AL, Naylor PH, McLane MF, Lee TH, Essex M. Antibody to human T-cell leukemia virus membrane antigens, beta 2-microglobulin levels, and thymosin alpha 1 levels in hemophiliacs and their spouses. Annals of Internal Medicine. 100: 178-82. PMID 6318630 DOI: 10.7326/0003-4819-100-2-178  0.269
2014 Wang R, Goyal R, Lei Q, Essex M, De Gruttola V. Sample size considerations in the design of cluster randomized trials of combination HIV prevention. Clinical Trials (London, England). 11: 309-318. PMID 24651566 DOI: 10.1177/1740774514523351  0.268
2012 Wester CW, Eden SK, Shepherd BE, Bussmann H, Novitsky V, Samuels DC, Hendrickson SL, Winkler CA, O'Brien SJ, Essex M, D'Aquila RT, DeGruttola V, Marlink RG. Risk factors for symptomatic hyperlactatemia and lactic acidosis among combination antiretroviral therapy-treated adults in Botswana: results from a clinical trial. Aids Research and Human Retroviruses. 28: 759-65. PMID 22540188 DOI: 10.1089/Aid.2011.0303  0.267
2011 Gezmu M, DeGruttola V, Dixon D, Essex M, Halloran E, Hogan J, Grobler A, Kim S, McDermott J, McKaig R, Neaton JD. Strengthening biostatistics resources in sub-Saharan Africa: research collaborations through U.S. partnerships. Statistics in Medicine. 30: 695-708. PMID 21394746 DOI: 10.1002/Sim.4144  0.267
1992 Tachibana N, Okayama A, Ishihara S, Shioiri S, Murai K, Tsuda K, Goya N, Matsuo Y, Essex M, Stuver S. High HTLV-I proviral DNA level associated with abnormal lymphocytes in peripheral blood from asymptomatic carriers. International Journal of Cancer. Journal International Du Cancer. 51: 593-5. PMID 1601522 DOI: 10.1002/Ijc.2910510415  0.265
2018 Zash R, Jacobson DL, Diseko M, Mayondi G, Mmalane M, Essex M, Gaolethe T, Petlo C, Lockman S, Holmes LB, Makhema J, Shapiro RL. Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study. The Lancet. Global Health. PMID 29880310 DOI: 10.1016/S2214-109X(18)30218-3  0.264
1987 Archibald DW, Barr CE, Torosian JP, McLane MF, Essex M. Secretory IgA antibodies to human immunodeficiency virus in the parotid saliva of patients with AIDS and AIDS-related complex. The Journal of Infectious Diseases. 155: 793-6. PMID 3469280 DOI: 10.1093/infdis/155.4.793  0.263
1996 Yu XF, Matsuda Z, Yu QC, Lee TH, Essex M. Role of the C terminus Gag protein in human immunodeficiency virus type 1 virion assembly and maturation. The Journal of General Virology. 3171-9. PMID 8847526 DOI: 10.1099/0022-1317-76-12-3171  0.263
1987 Marlink RG, Essex M. Africa and the Biology of Human Immunodeficiency Virus Jama: the Journal of the American Medical Association. 257: 2632-2633. PMID 3494858 DOI: 10.1001/jama.1987.03390190110032  0.262
2008 Kashala LO, Conne B, Kapanci Y, Frei PC, Lambert PH, Kalengayi MR, Essex M. Hepatitis B virus, alpha-fetoprotein synthesis, and hepatocellular carcinoma in Zaire. Liver. 12: 330-340. PMID 1280314 DOI: 10.1111/J.1600-0676.1992.Tb00582.X  0.256
1989 Yokota T, Cho MJ, Tachibana N, McLane MF, Takatsuki K, Lee TH, Mueller N, Essex M. The prevalence of antibody to p42 of HTLV-I among ATLL patients in comparison with healthy carriers in Japan. International Journal of Cancer. 43: 970-4. PMID 2786510 DOI: 10.1002/Ijc.2910430603  0.253
2008 Bussmann H, Wester CW, Ndwapi N, Grundmann N, Gaolathe T, Puvimanasinghe J, Avalos A, Mine M, Seipone K, Essex M, Degruttola V, Marlink RG. Five-year outcomes of initial patients treated in Botswana's National Antiretroviral Treatment Program. Aids (London, England). 22: 2303-11. PMID 18981769 DOI: 10.1097/Qad.0B013E3283129Db0  0.251
2022 Bareng OT, Moyo S, Zahralban-Steele M, Maruapula D, Ditlhako T, Mokaleng B, Mokgethi P, Choga WT, Moraka NO, Pretorius-Holme M, Mine MO, Raizes E, Molebatsi K, Motswaledi MS, Gobe I, ... ... Essex M, et al. HIV-1 drug resistance mutations among individuals with low-level viraemia while taking combination ART in Botswana. The Journal of Antimicrobial Chemotherapy. PMID 35229102 DOI: 10.1093/jac/dkac056  0.25
1988 Rojko J, Essex M, Trainin Z. Feline leukemia/sarcoma viruses and immunodeficiency Advances in Veterinary Science and Comparative Medicine. 32: 57-96. PMID 2847504  0.25
1986 Zon LI, Archibald DW, McLane MF, Essex M, Hepner MJ, Groopman JE. IgA deficiency and salivary transmission of human immunodeficiency virus. Lancet (London, England). 2: 1039-40. PMID 2877203 DOI: 10.1016/S0140-6736(86)92649-8  0.248
1979 Azocar J, Essex M. Susceptibility of human cell lines to feline leukemia virus and feline sarcoma virus Journal of the National Cancer Institute. 63: 1179-1184. PMID 228103 DOI: 10.1093/jnci/63.5.1179  0.242
2009 Novitsky V, Wang R, Lagakos S, Margolin L, Baca J, Kebaabetswe L, Rossenkhan R, Moyo S, Woldegabriel E, van Widenfelt E, Makhema J, Essex M. P20-12. Heterogeneity of Gag mutational pathways in primary HIV-1 subtype C infection Retrovirology. 6: P382. DOI: 10.1186/1742-4690-6-S3-P382  0.242
2011 Moyo S, Bussmann H, Mangwendeza P, Dusara P, Gaolathe T, Mine M, Musonda R, van Widenfelt E, Novitsky V, Makhema J, Marlink RG, Essex M, Wester CW. Validation of A Point-of-Care Lactate Device For Screening At-Risk Adults Receiving Combination Antiretroviral Therapy In Botswana. Journal of Antivirals & Antiretrovirals. 3: 45-48. PMID 23087782 DOI: 10.4172/Jaa.1000034  0.241
1996 Renjifo B, Chou K, Soto Ramirez L, Garcia Vallejo F, Essex M. Human T cell leukemia virus type I (HTLV-I) molecular genotypes and disease outcome. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association. S146-53. PMID 8797717 DOI: 10.1097/00042560-199600001-00023  0.24
1985 Allan JS, Coligan JE, Barin F, McLane MF, Sodroski JG, Rosen CA, Haseltine WA, Lee TH, Essex M. Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III Science. 228: 1091-1094. PMID 2986290 DOI: 10.1126/Science.2986290  0.236
2002 Cao H, Agrawal D, Kushner N, Touzjian N, Essex M, Lu Y. Delivery of Exogenous Protein Antigens to Major Histocompatibility Complex Class I Pathway in Cytosol The Journal of Infectious Diseases. 185: 244-251. PMID 11807699 DOI: 10.1086/338448  0.235
1984 Lee TH, Coligan JE, McLane MF, Sodroski JG, Popovic M, Wong-Staal F, Gallo RC, Haseltine W, Essex M. Serological cross-reactivity between envelope gene products of type I and type II human T-cell leukemia virus Proceedings of the National Academy of Sciences of the United States of America. 81: 7579-7583. PMID 6095307 DOI: 10.1073/Pnas.81.23.7579  0.234
1985 Groopman J, Hartzband P, Shulman L, Salahuddin S, Sarngadharan M, McLane M, Essex M, Gallo R. Antibody seronegative human T-lymphotropic virus type III (HTLV-III)- infected patients with acquired immunodeficiency syndrome or related disorders Blood. 66: 742-744. DOI: 10.1182/blood.v66.3.742.bloodjournal663742  0.234
1985 Kanki PJ, Alroy J, Essex M. Isolation of T-lymphotropic retrovirus relatedto HTLV-III/LAV from wild-caught African green monkeys Science. 230: 951-954. PMID 2997923 DOI: 10.1126/Science.2997923  0.234
1985 Groopman J, Hartzband P, Shulman L, Salahuddin S, Sarngadharan M, McLane M, Essex M, Gallo R. Antibody seronegative human T-lymphotropic virus type III (HTLV-III)- infected patients with acquired immunodeficiency syndrome or related disorders Blood. 66: 742-744. DOI: 10.1182/Blood.V66.3.742.742  0.233
2007 Wester CW, Okezie OA, Thomas AM, Bussmann H, Moyo S, Muzenda T, Makhema J, van Widenfelt E, Musonda R, Novitsky V, Gaolathe T, Ndwapi N, Essex M, Kuritzkes DR, DeGruttola V, et al. Higher-than-expected rates of lactic acidosis among highly active antiretroviral therapy-treated women in Botswana: preliminary results from a large randomized clinical trial. Journal of Acquired Immune Deficiency Syndromes (1999). 46: 318-22. PMID 18090299 DOI: 10.1097/Qai.0B013E3181568E3F  0.233
2010 Chigwedere P, Essex M. AIDS denialism and public health practice Aids and Behavior. 14: 237-247. PMID 20058063 DOI: 10.1007/s10461-009-9654-7  0.231
1985 Kanki PJ, McLane MF, King NW, Letvin NL, Hunt RD, Sehgal P, Daniel MD, Desrosiers RC, Essex M. Serologic identification and characterization of a macaque T-lymphotropic retrovirus closely related to HTLV-III. Science (New York, N.Y.). 228: 1199-201. PMID 3873705 DOI: 10.1126/Science.3873705  0.23
1986 Hirsch V, Riedel N, Kornfeld H, Kanki PJ, Essex M, Mullins JI. Cross-reactivity to human T-lymphotropic virus type III/lymphadenopathy-associated virus and molecular cloning of simian T-cell lymphotropic virus type III from African green monkeys Proceedings of the National Academy of Sciences of the United States of America. 83: 9754-9758. PMID 3491989 DOI: 10.1073/Pnas.83.24.9754  0.23
1978 De Noronha F, Schäfer W, Essex M, Bolognesis DP. Influence of antisera to oncornavirus glycoprotein (gp71) on infections of cats with feline leukemia virus Virology. 85: 617-621. PMID 208242 DOI: 10.1016/0042-6822(78)90467-1  0.227
2019 Moyo S, Gaseitsiwe S, Zahralban-Steele M, Maruapula D, Nkhisang T, Mokaleng B, Mohammed T, Ditlhako TR, Bareng OT, Mokgethi TP, van Widenfelt E, Pretorius-Holme M, Mine MO, Raizes E, Yankinda EK, ... ... Essex M, et al. Low rates of NRTI and NNRTI drug resistance among participants in the Botswana combination prevention program (BCPP) trial. Aids (London, England). PMID 30741821 DOI: 10.1097/QAD.0000000000002166  0.226
1991 Essex M. Sound policy, not AIDS hysteria Aids Research and Human Retroviruses. 7. PMID 1931227 DOI: 10.1089/Aid.1991.7.V  0.226
2009 Boutwell CL, Rowley CF, Essex M. Reduced viral replication capacity of human immunodeficiency virus type 1 subtype C caused by cytotoxic-T-lymphocyte escape mutations in HLA-B57 epitopes of capsid protein. Journal of Virology. 83: 2460-8. PMID 19109381 DOI: 10.1128/JVI.01970-08  0.226
1983 Essex M, McLane MF, Lee TH, Falk L, Howe CWS, Mullins JI, Cabradilla C, Francis DP. Antibodies to cell membrane antigens associated with human T-cell leukemia virus in patients with AIDS Science. 220: 859-862. PMID 6342136 DOI: 10.1126/Science.6342136  0.226
1985 Barin F, Denis F, Allan JS, M'Boup S, Kanki P, Lee TH, Essex M. SEROLOGICAL EVIDENCE FOR VIRUS RELATED TO SIMIAN T-LYMPHOTROPIC RETROVIRUS III IN RESIDENTS OF WEST AFRICA The Lancet. 326: 1387-1389. PMID 2867393 DOI: 10.1016/S0140-6736(85)92556-5  0.224
2007 Thior I, Gabaitiri L, Grimes J, Shapiro R, Lockman S, Kim S, Kebaabetswe P, Garmey E, Montano M, Peter T, Chang SY, Marlink R, Essex M. Voluntary counseling and testing among post-partum women in Botswana. Patient Education and Counseling. 65: 296-302. PMID 17029865 DOI: 10.1016/J.Pec.2006.08.010  0.223
1978 Francis DP, Essex M. Leukemia and lymphoma: Infrequent manifestations of common viral infections? a review Journal of Infectious Diseases. 138: 916-923. PMID 216756 DOI: 10.1093/infdis/138.6.916  0.221
1981 Francis DP, Essex M, Maynard JE. Feline leukemia virus and hepatitis B virus: a comparison of late manifestations Progress in Medical Virology. Fortschritte Der Medizinischen Virusforschung. Progres En Virologie Medicale. 27: 127-132. PMID 6262865  0.221
1982 Lee TH, Essex M, de Noronha F, Azocar J. Neutralization of Feline Leukemia Virus with Feline Antisera to Leukocyte Alloantigens Cancer Research. 42: 3995-3999. PMID 6286102  0.22
2022 Maseng MJ, Tawe L, Thami PK, Moyo S, Kasvosve I, Novitsky V, Essex M, Russo G, Gaseitsiwe S, Paganotti GM. The role of CYP2B6 516G>T polymorphism on efavirenz/nevirapine toxicity. Implications on treatment outcomes: Lessons from Botswana. Medicine. 101: e29066. PMID 35512066 DOI: 10.1097/MD.0000000000029066  0.22
1985 Groopman JE, Sarngadharan MG, Salahuddin SZ, Buxbaum R, Huberman MS, Kinniburgh J, Sliski A, McLane MF, Essex M, Gallo RC. Apparent transmission of human T-cell leukemia virus type III to a heterosexual woman with the acquired immunodeficiency syndrome. Annals of Internal Medicine. 102: 63-6. PMID 2981497 DOI: 10.7326/0003-4819-102-1-63  0.218
2013 Shapiro RL, Rossi S, Ogwu A, Moss M, Leidner J, Moffat C, Lockman S, Moyo S, Makhema J, Essex M, Capparelli E. Therapeutic levels of lopinavir in late pregnancy and abacavir passage into breast milk in the Mma Bana Study, Botswana Antiviral Therapy. 18: 585-590. PMID 23183881 DOI: 10.3851/Imp2474  0.218
1987 Archibald DW, Witt DJ, Craven DE, Vogt MW, Hirsch MS, Essex M. Antibodies to human immunodeficiency virus in cervical secretions from women at risk for AIDS. The Journal of Infectious Diseases. 156: 240-1. PMID 3474299 DOI: 10.1093/infdis/156.1.240  0.218
1983 Romet-Lemonne JL, McLane MF, Elfassi E, Haseltine WA, Azocar J, Essex M. Hepatitis B virus infection in cultured human lymphoblastoid cells. Science (New York, N.Y.). 221: 667-9. PMID 6867736 DOI: 10.1126/Science.6867736  0.216
2008 Lu Y, Essex M, Roberts B. Emerging infections in Asia Emerging Infections in Asia. 1-250. DOI: 10.1007/978-0-387-75722-3  0.214
1988 Sureau C, Eichberg JW, Hubbard GB, Romet-Lemonne JL, Essex M. A molecularly cloned hepatitis B virus produced in vitro is infectious in a chimpanzee Journal of Virology. 62: 3064-3067. PMID 3392775 DOI: 10.1128/jvi.62.8.3064-3067.1988  0.213
1980 Gazit E, Azocar J, Essex M, J. Yunis E. Modulatory changes of HLA antigens during culture of lymphoblastoid cell lines Human Immunology. 1: 258. DOI: 10.1016/0198-8859(80)90039-7  0.21
1989 Chen YM, Lee TH, Samuel KP, Okayama A, Tachibana N, Miyoshi I, Papas TS, Essex M. Antibody reactivity to different regions of human T-cell leukemia virus type 1 gp61 in infected people. Journal of Virology. 63: 4952-7. PMID 2677406 DOI: 10.1128/Jvi.63.11.4952-4957.1989  0.209
1986 Archibald D, Zon L, Groopman J, McLane M, Essex M. Antibodies to human T-lymphotropic virus type III (HTLV-III) in saliva of acquired immunodeficiency syndrome (AIDS) patients and in persons at risk for AIDS Blood. 67: 831-834. DOI: 10.1182/Blood.V67.3.831.Bloodjournal673831  0.207
1993 Yu X, Matsuda Z, Yu QC, Lee TH, Essex M. Vpx of simian immunodeficiency virus is localized primarily outside the virus core in mature virions. Journal of Virology. 67: 4386-90. PMID 8510227 DOI: 10.1128/Jvi.67.7.4386-4390.1993  0.207
1984 Lee TH, Coligan JE, Homma T, McLane MF, Tachibana N, Essex M. Human T-cell leukemia virus-associated membrane antigens: identity of the major antigens recognized after virus infection. Proceedings of the National Academy of Sciences of the United States of America. 81: 3856-60. PMID 6328528 DOI: 10.1073/pnas.81.12.3856  0.206
1980 Grant CK, Essex M, Gardner MB, Hardy WD. Natural Feline Leukemia Virus Infection and the Immune Response of Cats of Different Ages Cancer Research. 40: 823-829. PMID 6258787  0.205
1985 Ganguly K, Essex M. Feline leukemia virus-and feline sarcoma virus-related polypeptides released by virus producer and nonproducer cells. Cancer Investigation. 3: 523-34. PMID 3002564 DOI: 10.3109/07357908509039814  0.204
1986 Nahmias AJ, Weiss J, Yao X, Lee F, Kodsi R, Schanfield M, Matthews T, Bolognesi D, Durack D, Motulsky A, Kanki P, Essex M. EVIDENCE FOR HUMAN INFECTION WITH AN HTLV III/LAV-LIKE VIRUS IN CENTRAL AFRICA, 1959 The Lancet. 327: 1279-1280. PMID 2872424 DOI: 10.1016/S0140-6736(86)91422-4  0.204
1979 Azocar J, Essex M. Incorporation of HLA Antigens into the Envelope of RNA Tumor Viruses Grown in Human Cells Cancer Research. 39: 3388-3391. PMID 225020  0.204
1977 Cotter SM, Essex M. Animal model of human disease: acute lymphoblastic leukemia, aplastic anemia American Journal of Pathology. 87: 265-268. PMID 265690  0.202
1974 Physicochemical D, Essex M. Glycolysis during early infection of feline and human cells with feline leukemia virus Infection and Immunity. 9: 824-827. PMID 4363231  0.2
1979 Mandel MP, Stephenson JR, Hardy WD, Essex M. Endogenous RD-114 virus of cats: absence of antibodies to RD-114 envelope antigens in cats naturally exposed to feline leukemia virus. Infection and Immunity. 24: 282-5. PMID 222681 DOI: 10.1128/Iai.24.1.282-285.1979  0.2
1985 Daniel MD, Letvin NL, King NW, Kannagi M, Sehgal PK, Hunt RD, Kanki PJ, Essex M, Desrosiers RC. Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science (New York, N.Y.). 228: 1201-4. PMID 3159089 DOI: 10.1126/Science.3159089  0.198
1990 Yu XF, Matsuda M, Essex M, Lee TH. Open reading frame vpr of simian immunodeficiency virus encodes a virion-associated protein Journal of Virology. 64: 5688-5693. PMID 2145446 DOI: 10.1128/Jvi.64.11.5688-5693.1990  0.198
1985 Barin F, McLane MF, Allan JS, Lee TH, Groopman JE, Essex M. Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients. Science (New York, N.Y.). 228: 1094-6. PMID 2986291 DOI: 10.1126/science.2986291  0.198
1983 Azocar J, Essex M, Yunis EJ. Cell culture density modulates the incorporation of HLA antigens by enveloped viruses Human Immunology. 7: 59-65. PMID 6305890 DOI: 10.1016/S0198-8859(83)80006-8  0.196
1984 Calender A, Gessain A, Essex M, Thé Gd. SEROEPIDEMIOLOGY OF HUMAN T‐CELL LEUKEMIA VIRUS IN THE FRENCH WEST INDIES: ANTIBODIES IN BLOOD DONORS AND PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES WHO DO NOT HAVE AIDS Annals of the New York Academy of Sciences. 437: 175-176. PMID 6099999 DOI: 10.1111/j.1749-6632.1984.tb37133.x  0.196
1979 Francis DP, Cotter SM, Essex M, Hardy WD. Comparison of Virus-positive and Virus-negative Cases of Feline Leukemia and Lymphoma 1 Cancer Research. 39: 3866-3870. PMID 225010  0.196
1979 Francis DP, Essex M, Gayzagian D. Feline leukemia virus: Survival under home and laboratory conditions Journal of Clinical Microbiology. 9: 154-156. PMID 219019  0.194
2014 Russell ES, Mohammed T, Smeaton L, Jorowe B, MacLeod IJ, Hoffman RM, Currier JS, Moyo S, Essex M, Lockman S. Changes in inflammatory marker concentrations between the third trimester and six months postpartum. Plos One. DOI: 10.1371/Journal.Pone.0089928.G003  0.192
1984 Homma T, Kanki PJ, King NW, Hunt RD, O'Connell MJ, Letvin NL, Daniel MD, Desrosiers RC, Yang CS, Essex M. Lymphoma in macaques: association with virus of human T lymphotrophic family. Science (New York, N.Y.). 225: 716-8. PMID 6087453 DOI: 10.1126/Science.6087453  0.192
1977 Francis DP, Essex M, Hardy WD. Excretion of feline leukaemia virus by naturally infected pet cats Nature. 269: 252-254. PMID 201852 DOI: 10.1038/269252a0  0.191
1987 Kanki PJ, Barin F, M'Boup S, Essex M. Relationship of simian T-lymphotropic virus type III to human retroviruses in Africa Antibiotics and Chemotherapy. 38: 21-27. PMID 2889421  0.191
1973 Essex M, Cotter SM, Carpenter JL. Feline virus induced tumors and the immune response: recent developments American Journal of Veterinary Research. 34: 809-812. PMID 4350543  0.19
1996 Offor E, Garcia F, Essex M. HTLV-1 infection in asymtomatic individuals and patients in Nigeria Medical Science Research. 24: 583-584.  0.19
1984 Lee TH, Coligan JE, Sodroski JG, Haseltine WA, Salahuddin SZ, Wong-Staal F, Gallo RC, Essex M. Antigens encoded by the 3′-terminal region of human T-cell leukemia virus: Evidence for a functional gene Science. 226: 57-61. PMID 6089350 DOI: 10.1126/Science.6089350  0.19
1979 Sliski AH, Essex M. Sarcoma virus-induced transformation specific antigen: Presence of antibodies in cats that were naturally exposed to leukemia virus Virology. 95: 581-586. PMID 88797 DOI: 10.1016/0042-6822(79)90512-9  0.189
1995 Trujillo JR, Garc??a-Ramos G, Novak IS, Rivera VM, Huerta E, Essex M. Neurologic Manifestations of AIDS Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 8: 23???29. DOI: 10.1097/00042560-199501000-00005  0.188
1975 Essex M, Hardy WD, Cotter SM, Jakowski RM. Immune response of healthy and leukemic cats to the feline oncornavirus associated cell membrane antigen Bibliotheca Haematologica. 483-488. PMID 169820 DOI: 10.1159/000397565  0.188
1985 Kitchen L, Leal M, Wichmann I, Lissen E, Ollero M, Allan J, McLane M, Essex M. Antibodies to human T-cell leukemia virus type III in hemophiliacs from Spain Blood. 66: 1473-1475. DOI: 10.1182/blood.v66.6.1473.bloodjournal6661473  0.187
1985 Kitchen L, Leal M, Wichmann I, Lissen E, Ollero M, Allan J, McLane M, Essex M. Antibodies to human T-cell leukemia virus type III in hemophiliacs from Spain Blood. 66: 1473-1475. DOI: 10.1182/blood.v66.6.1473.1473  0.187
1983 Essex M, McLane MF, Lee TH, Tachibana N, Mullins JI, Kreiss J, Kasper CK, Poon MC, Landay A, Stein SF, Francis DP, Cabradilla C, Lawrence DN, Evatt BL. Antibodies to human T-cell leukemia virus membrane antigens (HTLV-MA) in hemophiliacs. Science (New York, N.Y.). 221: 1061-4. PMID 6603659 DOI: 10.1126/Science.6603659  0.186
1975 Essex M. Neoplasms of cats caused by oncornaviruses Pathobiol.Annual. 169-195. PMID 172836  0.186
1985 Allan JS, Coligan JE, Lee TH, McLane MF, Kanki PJ, Groopman JE, Essex M. A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients Science. 230: 810-813. PMID 2997921 DOI: 10.1126/Science.2997921  0.184
1990 Chen YM, Lee TH, Wiktor SZ, Shaw GM, Murphy EL, Blattner WA, Essex M. Type-specific antigens for serological discrimination of HTLV-I and HTLV-II infection. Lancet (London, England). 336: 1153-5. PMID 1978028 DOI: 10.1016/0140-6736(90)92769-E  0.183
1976 Cerny J, Essex M, Thomas DB. Interactions of murine leukemia virus (MuLV) with isolated lymphocytes. III. Alterations of splenic B and T cells in Friend virus infected mice International Journal of Cancer. 18: 197-204. PMID 60287  0.182
1984 Shaw GM, Broder S, Essex M, Gallo RC. Human T-cell leukemia virus: its discovery and role in leukemogenesis and immunosuppression Advances in Internal Medicine. 30: 1-27. PMID 6084947  0.18
1986 Rotbart HA, Levin MJ, Jones JF, Hayward AR, Allan J, McLane MF, Essex M. Noma in children with severe combined immunodeficiency. The Journal of Pediatrics. 109: 596-600. PMID 3020218 DOI: 10.1016/S0022-3476(86)80219-0  0.18
1983 Jameson P, Essex M. Inhibition of feline leukemia virus replication by human leukocyte interferon Antiviral Research. 3: 115-120. PMID 6312876 DOI: 10.1016/0166-3542(83)90033-5  0.18
2014 Russell ES, Mohammed T, Smeaton L, Jorowe B, MacLeod IJ, Hoffman RM, Currier JS, Moyo S, Essex M, Lockman S. Selection of subcohorts. Plos One. DOI: 10.1371/Journal.Pone.0089928.G001  0.179
1984 Sodroski J, Patarca R, Perkins D, Briggs D, Lee TH, Essex M, Coligan J, Wong-Staal F, Gallo RC, Haseltine WA. Sequence of the envelope glycoprotein gene of type II human T lymphotropic virus. Science (New York, N.Y.). 225: 421-4. PMID 6204380 DOI: 10.1126/Science.6204380  0.177
1975 Cerny J, Essex M, Rich MA, Hardy WD. Expression of virus-associated antigens and immune cell functions during spontaneous regression of the Friend viral murine leukemia. International Journal of Cancer. Journal International Du Cancer. 15: 351-65. PMID 47847 DOI: 10.1002/ijc.2910150219  0.174
1984 Lee TH, Coligan JE, Essex M. Human T-cell leukemia virus specific antigens Princess Takamatsu Symposia. 15: 197-203. PMID 6100639  0.174
1983 Romet Lemmonne JL, Elfassi E, Haseltine W, Essex M. Infection of bone marrow cells by hepatitis B virus Lancet. 2: 732. PMID 6136855 DOI: 10.1016/S0140-6736(83)92264-X  0.173
1986 Lee TH, Essex M, Klein E, Klein G. Human T-cell leukemia virus-associated nuclear antigen (HTLV-NA) Immunology Letters. 13: 19-24. PMID 2428740 DOI: 10.1016/0165-2478(86)90120-3  0.171
1975 Cotter SM, Hardy WD, Essex M. Association of feline leukemia virus with lymphosarcoma and other disorders in the cat Journal of the American Veterinary Medical Association. 166: 449-454. PMID 163223  0.171
1987 Allan JS, Coligan JE, Lee TH, Barin F, Kanki PJ, M'Boup S, McLane MF, Groopman JE, Essex M. Immunogenic nature of a pol gene product of HTLV-III/LAV Blood. 69: 331-333. PMID 3024760  0.17
1990 Bacha A, Roingeard P, Coll AM, Essex M, M'Boup S. Hepatitis delta virus antibodies in hepatitis B surface antigen asymptomatic carriers in Senegal. The Journal of Infectious Diseases. 161: 150-1. PMID 2295849 DOI: 10.1093/infdis/161.1.150  0.169
1985 Kanki PJ, Kurth R, Becker W, Dreesman G, Mclane MF, Essex M. ANTIBODIES TO SIMIAN T-LYMPHOTROPIC RETROVIRUS TYPE III IN AFRICAN GREEN MONKEYS AND RECOGNITION OF STLV-III VIRAL PROTEINS BY AIDS AND RELATED SERA The Lancet. 325: 1330-1332. PMID 2860515 DOI: 10.1016/S0140-6736(85)92818-1  0.166
1984 Elfassi E, Romet-Lemonne JL, Essex M. Evidence of extrachromosomal forms of hepatitis B viral DNA in a bone marrow culture obtained from a patient recently infected with hepatitis B virus Proceedings of the National Academy of Sciences of the United States of America. 81: 3526-3528. PMID 6587366 DOI: 10.1073/Pnas.81.11.3526  0.164
1971 Essex M, Klein G, Snyder SP, Boyd Harrold J. Antibody to feline oncornavirus-associated cell membrane antigen in neonatal cats International Journal of Cancer. 8: 384-390. PMID 4944746 DOI: 10.1002/Ijc.2910080305  0.161
1986 Kreiss JK, Kitchen LW, Prince HE, Kasper CK, Goldstein AL, Naylor PH, Preble O, Stewart JA, Essex M. Human T cell leukemia virus type III antibody, lymphadenopathy, and acquired immune deficiency syndrome in hemophiliac subjects. Results of a prospective study. The American Journal of Medicine. 80: 345-50. PMID 3006485 DOI: 10.1016/0002-9343(86)90704-7  0.16
1985 Sandstrom EG, Schooley RT, Ho DD, Byington R, Sarngadharan MG, MacLane ME, Essex M, Gallo RC, Hirsch MS. Detection of human anti-HTLV-III antibodies by indirect immunofluorescence using fixed cells. Transfusion. 25: 308-12. PMID 2992128 DOI: 10.1046/J.1537-2995.1985.25485273806.X  0.16
1985 Azócar J, Linares J, Essex M. Distribution of antibodies against the human T-cell leukemia virus in healthy Venezuelan adults Acta Cientifica Venezolana. 36: 170-172. PMID 3008469  0.155
1988 Tachibana N, Okayama A, Ishizaki J, Yokota T, Shishime E, Murai K, Shioiri S, Tsuda K, Essex M, Mueller N. Suppression of tuberculin skin reaction in healthy HTLV-I carriers from Japan. International Journal of Cancer. Journal International Du Cancer. 42: 829-31. PMID 3192326 DOI: 10.1002/ijc.2910420605  0.154
1973 Essex M, Snyder SP, Klein G. Relationship between humoral antibodies and the failure to develop progressive tumors in cats injected with feline sarcoma virus (FSV) Bibliotheca Haematologica. 771-777.  0.152
1976 Essex M, Francis DP. The risk to humans from malignant diseases of their pets: an unsettled issue Journal of the American Animal Hospital Association. 12: 386-390.  0.152
1971 Essex M, Klein G, Snyder SP, Harrold JB. Correlation between humoral antibody and regression of tumours induced by feline sarcoma virus Nature. 233: 195-196. PMID 4939178 DOI: 10.1038/233195a0  0.149
1990 Verdier M, Denis F, Leonard G, Sangare A, Patillaud S, Prince-David M, Essex M. Comparison of immunofluorescence, particle agglutination, and enzyme immunoassays for detection of human T-cell leukemia virus type I antibody in African sera. Journal of Clinical Microbiology. 28: 1988-93. PMID 2229382 DOI: 10.1128/jcm.28.9.1988-1993.1990  0.149
1984 Chen APT, Essex ME. Infection with feline leukemia virus associated with induction of humoral response to a normal cell protein Cancer Investigation. 2: 81-90. PMID 6329486 DOI: 10.3109/07357908409020290  0.149
1976 Hardy WD, Essex M, Sliski A, Cotter SM. Immune Response to Leukemia Virus and Tumor-associated Antigens in Cats Cancer Research. 36: 640-645. PMID 56224  0.146
1972 Essex M, Kawakami TG, Kurata K. Continuous Long-Term Replication of Feline Leukemia Virus (FeLV) in an Established Canine Cell Culture (MDCK) Proceedings of the Society For Experimental Biology and Medicine. 139: 295-299. PMID 4621402 DOI: 10.3181/00379727-139-36129  0.146
1979 Kurth R, Fenyö EM, Klein E, Essex M. Cell-surface antigens induced by RNA tumour viruses Nature. 279: 197-201. PMID 220541 DOI: 10.1038/279197a0  0.146
1975 Schaller JP, Essex M, Yohn DS, Olsen RG. Feline oncornavirus associated cell membrane antigen. V. Humoral immune response to virus and cell membrane antigens in cats inoculated with Gardner Arnstein feline sarcoma virus Journal of the National Cancer Institute. 55: 1373-1378. PMID 1206756  0.143
1988 Kanki PJ, Essex M. Simian T-lymphoctropic viruses and related human viruses Veterinary Microbiology. 17: 309-314. PMID 2847395 DOI: 10.1016/0378-1135(88)90072-7  0.141
1986 Lee TH, Coligan JE, Allan JS, McLane MF, Groopman JE, Essex M. A new HTLV-III/LAV protein encoded by a gene found in cytopathic retroviruses. Science (New York, N.Y.). 231: 1546-9. PMID 3006243 DOI: 10.1126/science.3006243  0.14
1991 Korber B, Okayama A, Donnelly R, Tachibana N, Essex M. Polymerase chain reaction analysis of defective human T-cell leukemia virus type I proviral genomes in leukemic cells of patients with adult T-cell leukemia. Journal of Virology. 65: 5471-6. PMID 1895396 DOI: 10.1128/jvi.65.10.5471-5476.1991  0.139
1997 Hehlmann R, Essex M. Comparative research on leukemia and related diseases: An introduction to a scientific approach Journal of Molecular Medicine. 75: 528-538. PMID 9253716  0.137
1999 Hehlmann R, Essex M. Comparative research in Leukemia and related diseases. An introduction to a scientific approach Leukemia. 13: 19-28. DOI: 10.1038/sj.leu.2401289  0.136
1992 Essex M. Immunopathogenesis of HTLV Aids Research and Human Retroviruses. 8: 719-724. PMID 1355347  0.135
1983 Curran JW, Essex M, Francis DP. Epidemic acquired immune deficiency syndrome: Epidemiologic evidence for a transmissible agent Journal of the National Cancer Institute. 71: 1-4. PMID 6575197  0.132
1981 Essex M, Grant CK, Cotter SM, Hardy WD. Role of viruses in the etiology of naturally occurring feline leukemia Hamatologie Und Bluttransfusion. 26: 483-487. PMID 6274762 DOI: 10.1007/978-3-642-67984-1_88  0.13
1986 Kennedy RC, Henkel RD, Pauletti D, Allan JS, Lee TH, Essex M, Dreesman GR. Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein. Science (New York, N.Y.). 231: 1556-9. PMID 3006246 DOI: 10.1126/science.3006246  0.128
1991 Calderón EJ, Gómez-Lucia E, Aguado I, Pineda JA, Essex M, Leal M. Absence of HTLV-I and HTLV-II infection in prostitutes in the area of Seville, Spain. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. 10: 773-5. PMID 1810736 DOI: 10.1007/BF01972509  0.124
1980 Cohen D, Essex M. Feline leukemia in israel: Prevalence of antibody to feline oncornavirus-associated cell membrane antigen in stray cats Intervirology. 13: 342-347. PMID 6252115 DOI: 10.1159/000149144  0.121
1977 Stephenson JR, Essex M, Hino S, Hardy WD, Aaronson SA. Feline oncornavirus-associated cell-membrane antigen (FOCMA): distinction between FOCMA and the major virion glycoprotein. Proceedings of the National Academy of Sciences of the United States of America. 74: 1219-23. PMID 191832 DOI: 10.1073/Pnas.74.3.1219  0.12
1981 Chen AP, Essex M, Shadduck JA, Niederkorn JY, Albert D. Retrovirus-encoded transformation-specific polyproteins: expression coordinated with malignant phenotype in cells from different germ layers. Proceedings of the National Academy of Sciences of the United States of America. 78: 3915-9. PMID 6973761 DOI: 10.1073/pnas.78.6.3915  0.12
2005 Essex M. Retrovirology. 2: S124. DOI: 10.1186/1742-4690-2-S1-S124  0.12
1988 Kakoma I, Ristic M, Essex M. Foreword Veterinary Microbiology. 17: 195-196.  0.12
1981 Coffin JM, Varmus HE, Bishop JM, Essex M, Hardy WD, Martin GS, Rosenberg NE, Scolnick EM, Weinberg RA, Vogt PK. Proposal for naming host cell-derived inserts in retrovirus genomes. Journal of Virology. 40: 953-7. PMID 7321107 DOI: 10.1128/Jvi.40.3.953-957.1981  0.117
1979 Francis DP, Essex M, Cotter SM, Gayzagian D, Hamm D. A simple method for quantitating salivary levels of virus using calcium alginate swabs. Journal of Clinical Pathology. 32: 514-5. PMID 224079 DOI: 10.1136/jcp.32.5.514  0.114
1992 Ganguly K, Essex M. Retrovirus transformation associated secretory phosphoproteins of mouse and mink cells. Cellular and Molecular Biology. 38: 41-7. PMID 1559243  0.112
1981 Niederkorn JY, Shadduck JA, Albert D, Essex M. Serum antibodies against feline oncornavirus-associated cell membrane antigen in cats bearing virally induced uveal melanomas Investigative Ophthalmology and Visual Science. 20: 598-605. PMID 6260702  0.112
1973 Essex M, Snyder SP. Feline oncornavirus-associated cell membrane antigen. I. serologic studies with kittens exposed to cell-free materials from various feline fibrosarcomas Journal of the National Cancer Institute. 51: 1007-1012. PMID 4743550 DOI: 10.1093/jnci/51.3.1007  0.112
1981 Essex M, Gutensohn N. A comparison of the pathobiology and epidemiology of cancers associated with viruses in humans and animals Progress in Medical Virology. Fortschritte Der Medizinischen Virusforschung. Progres En Virologie Medicale. 27: 114-126. PMID 6262864  0.103
1986 Hardy WD, Essex M. FeLV-induced feline acquired immune deficiency syndrome. A model for human AIDS Progress in Allergy. 37: 353-376. PMID 3008168  0.097
1976 Essex M, Sliski A, Cotter SM, Jakowski RR, Hardy WD. Immunosurveillance of naturally occurring feline leukemia. Science (New York, N.Y.). 190: 790-2. PMID 173019 DOI: 10.1126/science.173019  0.092
1981 Rhim JS, Koh KS, Chen A, Essex M. Characterization of clones of tumorigenic feline cells transformed by a chemical carcinogen International Journal of Cancer. 28: 51-57. PMID 6273330  0.09
1977 Essex M, Hardy WD. Transmissibility of animal cancer viruses Journal of the American Veterinary Medical Association. 171. PMID 200591  0.09
1992 Kashala LO, Kalengayi MMR, Essex M. Alpha-fetoprotein synthesis in human hepatocellular carcinoma: Correlation with hepatitis b surface antigen expression Cancer Investigation. 10: 513-522. PMID 1384940 DOI: 10.3109/07357909209024813  0.087
1974 Cerny J, Essex M. Membrane antigens of murine leukaemia cells Nature. 251: 742-745. PMID 4372537 DOI: 10.1038/251742a0  0.08
1983 Chen AP, Essex M, de Noronha F. Detection and localization of a phosphotyrosine-containing onc gene product in feline tumor cells Hamatologie Und Bluttransfusion. 28: 227-235. PMID 6190715  0.078
1982 Azocar J, Yunis EJ, Essex M. SENSITIVITY OF HUMAN NATURAL KILLER CELLS TO HYPERTHERMIA The Lancet. 319: 16-17. PMID 6172681 DOI: 10.1016/S0140-6736(82)92558-2  0.065
Hide low-probability matches.